1.1 	A bill for an act
1.2 	relating to cannabis; including the Office of Cannabis Management as an agency 
1.3 	for the purpose of having a government-to-government relationship with Tribal 
1.4 	governments; modifying medical cannabis provisions; modifying provisions 
1.5 	regarding the sale of cannabinoids derived from hemp; modifying the limits of 
1.6 	certain cannabinoids in lower-potency hemp edibles; establishing a license and 
1.7 	fee for lower-potency hemp edible wholesalers; providing for delivery of 
1.8 	lower-potency hemp edibles; regulating certain products intended for export; 
1.9 	modifying regulations on the transportation of cannabis and hemp; providing for 
1.10 	cannabis testing facility accreditation; modifying labeling requirements; modifying 
1.11 	cannabis license qualifications and application requirements; authorizing 
1.12 	municipalities to hold cannabis and hemp licenses; allowing samples at cannabis 
1.13 	events; modifying expungement and resentencing provisions for felony cannabis 
1.14 	offenses; requiring a proposal to the legislature; making technical and conforming 
1.15 	changes;amending Minnesota Statutes 2024, sections 10.65, subdivision 2; 151.72, 
1.16 	subdivisions 3, 5a; 152.22, subdivisions 4, 7, 10, 13; 152.24; 152.25; 152.26; 
1.17 	152.261; 152.27, subdivisions 2, 7; 152.28, subdivisions 1, 3; 152.29, subdivisions 
1.18 	1, 2, 3a, 4; 152.31; 152.32, subdivision 2; 152.33, subdivisions 1a, 4; 152.35; 
1.19 	152.37; 342.01, subdivisions 9, 34, 47, 48, 50, 71, by adding subdivisions; 342.02, 
1.20 	subdivision 3; 342.09, subdivision 2; 342.10; 342.11; 342.12; 342.13; 342.14, 
1.21 	subdivisions 1, 3, 6; 342.151, subdivisions 2, 3; 342.16; 342.17; 342.18, subdivision 
1.22 	2; 342.22, subdivision 3, by adding a subdivision; 342.28, subdivisions 1, 8; 342.29, 
1.23 	subdivisions 1, 7; 342.30, subdivision 1; 342.32, subdivisions 1, 4, 5; 342.33, 
1.24 	subdivision 1; 342.34, subdivision 5; 342.36, subdivision 6; 342.37, subdivision 
1.25 	2, by adding subdivisions; 342.39, subdivision 3; 342.40, subdivision 7, by adding 
1.26 	a subdivision; 342.43, subdivisions 1, 2, by adding a subdivision; 342.44, 
1.27 	subdivision 1; 342.45, subdivision 1, by adding subdivisions; 342.46, subdivisions 
1.28 	1, 3, 4, 5, 6, 7, 8, 9, by adding subdivisions; 342.51, subdivision 2, by adding a 
1.29 	subdivision; 342.515, subdivisions 1, 7; 342.52, subdivision 9, by adding a 
1.30 	subdivision; 342.56, subdivision 2; 342.57; 342.59, subdivision 2; 342.61, 
1.31 	subdivision 4; 342.62, subdivision 2; 342.63, subdivisions 2, 3, 5, 6; 342.66, 
1.32 	subdivision 6; 609A.06, subdivisions 3, 7, 10, 12; proposing coding for new law 
1.33 	in Minnesota Statutes, chapter 342; repealing Minnesota Statutes 2024, sections 
1.34 	152.22, subdivision 2; 342.151, subdivision 1; 342.36, subdivision 5.
2.1 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

2.2 	Section 1. Minnesota Statutes 2024, section 10.65, subdivision 2, is amended to read:
2.3 		Subd. 2.Definitions. As used in this section, the following terms have the meanings 
2.4 	given:
2.5 	(1) "agency" means the Department of Administration; Department of Agriculture; 
2.6 	Department of Children, Youth, and Families; Department of Commerce; Department of 
2.7 	Corrections; Department of Education; Department of Employment and Economic 
2.8 	Development; Department of Health; Office of Higher Education; Housing Finance Agency; 
2.9 	Department of Human Rights; Department of Human Services; Department of Information 
2.10 	Technology Services; Department of Iron Range Resources and Rehabilitation; Department 
2.11 	of Labor and Industry; Minnesota Management and Budget; Bureau of Mediation Services; 
2.12 	Department of Military Affairs; Metropolitan Council; Department of Natural Resources; 
2.13 	Pollution Control Agency; Department of Public Safety; Department of Revenue; Department 
2.14 	of Transportation; Department of Veterans Affairs; Direct Care and Treatment; Gambling 
2.15 	Control Board; Racing Commission; the Minnesota Lottery; the Animal Health Board; the 
2.16 	Public Utilities Commission; and the Board of Water and Soil Resources; and the Office 
2.17 	of Cannabis Management;
2.18 	(2) "consultation" means the direct and interactive involvement of the Minnesota Tribal 
2.19 	governments in the development of policy on matters that have Tribal implications. 
2.20 	Consultation is the proactive, affirmative process of identifying and seeking input from 
2.21 	appropriate Tribal governments and considering their interest as a necessary and integral 
2.22 	part of the decision-making process. This definition adds to statutorily mandated notification 
2.23 	procedures. During a consultation, the burden is on the agency to show that it has made a 
2.24 	good faith effort to elicit feedback. Consultation is a formal engagement between agency 
2.25 	officials and the governing body or bodies of an individual Minnesota Tribal government 
2.26 	that the agency or an individual Tribal government may initiate. Formal meetings or 
2.27 	communication between top agency officials and the governing body of a Minnesota Tribal 
2.28 	government is a necessary element of consultation;
2.29 	(3) "matters that have Tribal implications" means rules, legislative proposals, policy 
2.30 	statements, or other actions that have substantial direct effects on one or more Minnesota 
2.31 	Tribal governments, or on the distribution of power and responsibilities between the state 
2.32 	and Minnesota Tribal governments;
2.33 	(4) "Minnesota Tribal governments" means the federally recognized Indian Tribes located 
2.34 	in Minnesota including: Bois Forte Band; Fond Du Lac Band; Grand Portage Band; Leech 
3.1 	Lake Band; Mille Lacs Band; White Earth Band; Red Lake Nation; Lower Sioux Indian 
3.2 	Community; Prairie Island Indian Community; Shakopee Mdewakanton Sioux Community; 
3.3 	and Upper Sioux Community; and
3.4 	(5) "timely and meaningful" means done or occurring at a favorable or useful time that 
3.5 	allows the result of consultation to be included in the agency's decision-making process for 
3.6 	a matter that has Tribal implications.

3.7 	Sec. 2. Minnesota Statutes 2024, section 151.72, subdivision 3, is amended to read:
3.8 		Subd. 3.Sale of cannabinoids derived from hemp. (a) Notwithstanding any other 
3.9 	section of this chapter, a product containing nonintoxicating cannabinoids, including an 
3.10 	edible cannabinoid product, may be sold for human or animal consumption only if all of 
3.11 	the requirements of this section are met. A product sold for human or animal consumption 
3.12 	must not contain more than 0.3 percent of any tetrahydrocannabinol and an edible 
3.13 	cannabinoid product must not contain an amount of any tetrahydrocannabinol that exceeds 
3.14 	the limits established in subdivision 5a, paragraph (f).
3.15 	(b) A product containing nonintoxicating cannabinoids, other than an edible cannabinoid 
3.16 	product, may be sold for human or animal consumption only if it is intended for application 
3.17 	externally to a part of the body of a human or animal. Such a product must not be 
3.18 	manufactured, marketed, distributed, or intended to be consumed:
3.19 	(1) by combustion or vaporization of the product and inhalation of smoke, aerosol, or 
3.20 	vapor from the product;
3.21 	(2) through chewing, drinking, or swallowing; or
3.22 	(3) through injection or application to nonintact skin or a mucous membrane or nonintact 
3.23 	skin, except for products applied sublingually.
3.24 	(c) No other substance extracted or otherwise derived from hemp may be sold for human 
3.25 	consumption if the substance is intended:
3.26 	(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention 
3.27 	of disease in humans or other animals; or
3.28 	(2) to affect the structure or any function of the bodies of humans or other animals.
3.29 	(d) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise 
3.30 	derived from hemp may be sold to any individual who is under the age of 21.
3.31 	(e) Products that meet the requirements of this section are not controlled substances 
3.32 	under section 152.02.
4.1 	(f) Products may be sold for on-site consumption if all of the following conditions are 
4.2 	met:
4.3 	(1) the retailer must also hold an on-sale license issued under chapter 340A;
4.4 	(2) products, other than products that are intended to be consumed as a beverage, must 
4.5 	be served in original packaging, but may be removed from the products' packaging by 
4.6 	customers and consumed on site;
4.7 	(3) products must not be sold to a customer who the retailer knows or reasonably should 
4.8 	know is intoxicated;
4.9 	(4) products must not be permitted to be mixed with an alcoholic beverage; and
4.10 	(5) products that have been removed from packaging must not be removed from the 
4.11 	premises.
4.12 	(g) Edible cannabinoid products that are intended to be consumed as a beverage may be 
4.13 	served outside of the products' packaging if the information that is required to be contained 
4.14 	on the label of an edible cannabinoid product is posted or otherwise displayed by the retailer.

4.15 	Sec. 3. Minnesota Statutes 2024, section 151.72, subdivision 5a, is amended to read:
4.16 		Subd. 5a.Additional requirements for edible cannabinoid products. (a) In addition 
4.17 	to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid 
4.18 	must meet the requirements of this subdivision.
4.19 	(b) An edible cannabinoid product must not:
4.20 	(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, 
4.21 	animal, or fruit that appeals to children;
4.22 	(2) be modeled after a brand of products primarily consumed by or marketed to children;
4.23 	(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a 
4.24 	commercially available candy or snack food item;
4.25 	(4) be substantively similar to a meat food product; poultry food product as defined in 
4.26 	section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 
4.27 	7;
4.28 	(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved 
4.29 	by the United States Food and Drug Administration for use in food;
4.30 	(6) be packaged in a way that resembles the trademarked, characteristic, or 
4.31 	product-specialized packaging of any commercially available food product; or
5.1 	(7) be packaged in a container that includes a statement, artwork, or design that could 
5.2 	reasonably mislead any person to believe that the package contains anything other than an 
5.3 	edible cannabinoid product.
5.4 	(c) An edible cannabinoid product must be prepackaged in packaging or a container that 
5.5 	is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is 
5.6 	child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The 
5.7 	requirement that packaging be child-resistant does not apply to an edible cannabinoid product 
5.8 	that is intended to be consumed as a beverage.
5.9 	(d) If an edible cannabinoid product, other than a product that is intended to be consumed 
5.10 	as a beverage, is intended for more than a single use or contains multiple servings, each 
5.11 	serving must be indicated by scoring, wrapping, or other indicators designating the individual 
5.12 	serving size that appear on the edible cannabinoid product. If it is not possible to indicate 
5.13 	a single serving by scoring or use of another indicator that appears on the product, the edible 
5.14 	cannabinoid product may not be packaged in a manner that includes more than a single 
5.15 	serving in each container, except that a calibrated dropper, measuring spoon, or similar 
5.16 	device for measuring a single serving, when sold with the product, may be used for any 
5.17 	edible cannabinoid products that are intended to be combined with food or beverage products 
5.18 	prior to consumption.
5.19 	(e) A label containing at least the following information must be affixed to the packaging 
5.20 	or container of all edible cannabinoid products sold to consumers:
5.21 	(1) the serving size;
5.22 	(2) the cannabinoid profile per serving and in total;
5.23 	(3) a list of ingredients, including identification of any major food allergens declared 
5.24 	by name; and
5.25 	(4) the following statement: "Keep this product out of reach of children."
5.26 	(f) An edible cannabinoid product that is not intended to be consumed as a beverage 
5.27 	must not contain more than five milligrams of any tetrahydrocannabinol in a single serving. 
5.28 	An edible cannabinoid product, other than a product that is intended to be consumed as a 
5.29 	beverage, may and must not contain more than a total of 50 milligrams of any 
5.30 	tetrahydrocannabinol per package. An edible cannabinoid product that is intended to be 
5.31 	consumed as a beverage may not contain more than two servings per container.
5.32 	(g) An edible cannabinoid product that is intended to be consumed as a beverage must 
5.33 	not contain more than ten milligrams of any tetrahydrocannabinol in a single container.
6.1 	(g)(h) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or 
6.2 	delta-9 tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is 
6.3 	an artificially derived cannabinoid. Edible cannabinoid products are prohibited from 
6.4 	containing any other artificially derived cannabinoid, including but not limited to THC-P, 
6.5 	THC-O, and HHC, unless the office authorizes use of the artificially derived cannabinoid 
6.6 	in edible cannabinoid products. Edible cannabinoid products are prohibited from containing 
6.7 	synthetic cannabinoids.
6.8 	(h) (i) Every person selling edible cannabinoid products to consumers, other than products 
6.9 	that are intended to be consumed as a beverage, must ensure that all edible cannabinoid 
6.10 	products are displayed behind a checkout counter where the public is not permitted or in a 
6.11 	locked case.

6.12 	Sec. 4. Minnesota Statutes 2024, section 152.22, subdivision 4, is amended to read:
6.13 		Subd. 4.Health care practitioner. "Health care practitioner" means a Minnesota licensed
6.14 	Minnesota-licensed doctor of medicine, a Minnesota licensed Minnesota-licensed physician 
6.15 	assistant acting within the scope of authorized practice, or a Minnesota licensed
6.16 	Minnesota-licensed advanced practice registered nurse who has an active license in good 
6.17 	standing and the primary responsibility for the care and treatment of the qualifying medical 
6.18 	condition of a person an individual diagnosed with a qualifying medical condition.

6.19 	Sec. 5. Minnesota Statutes 2024, section 152.22, subdivision 7, is amended to read:
6.20 		Subd. 7.Medical cannabis manufacturer. "Medical cannabis manufacturer" or 
6.21 	"manufacturer" means an entity registered by the commissioner office to cultivate, acquire, 
6.22 	manufacture, possess, prepare, transfer, transport, supply, or dispense medical cannabis, 
6.23 	delivery devices, or related supplies and educational materials.

6.24 	Sec. 6. Minnesota Statutes 2024, section 152.22, subdivision 10, is amended to read:
6.25 		Subd. 10.Patient registry number. "Patient registry number" means a unique 
6.26 	identification number assigned by the commissioner office to a patient enrolled in the registry 
6.27 	program.

6.28 	Sec. 7. Minnesota Statutes 2024, section 152.22, subdivision 13, is amended to read:
6.29 		Subd. 13.Registry verification. "Registry verification" means the verification provided 
6.30 	by the commissioner office that a patient is enrolled in the registry program and that includes 
7.1 	the patient's name, registry number, and, if applicable, the name of the patient's registered 
7.2 	designated caregiver or parent, legal guardian, or spouse.

7.3 	Sec. 8. Minnesota Statutes 2024, section 152.24, is amended to read:
7.4 	152.24 FEDERALLY APPROVED CLINICAL TRIALS.
7.5 	The commissioner office may prohibit enrollment of a patient in the registry program 
7.6 	if the patient is simultaneously enrolled in a federally approved clinical trial for the treatment 
7.7 	of a qualifying medical condition with medical cannabis. The commissioner office shall 
7.8 	provide information to all patients enrolled in the registry program on the existence of 
7.9 	federally approved clinical trials for the treatment of the patient's qualifying medical condition 
7.10 	with medical cannabis as an alternative to enrollment in the patient registry program.

7.11 	Sec. 9. Minnesota Statutes 2024, section 152.25, is amended to read:
7.12 	152.25 COMMISSIONER OFFICE DUTIES.
7.13 		Subdivision 1.Medical cannabis manufacturer registration. (a) The commissioner
7.14 	office shall register two in-state manufacturers for the production of all medical cannabis 
7.15 	within the state. A registration agreement between the commissioner office and a 
7.16 	manufacturer is nontransferable. The commissioner office shall register new manufacturers 
7.17 	or reregister the existing manufacturers by December 1 every two years, using the factors 
7.18 	described in this subdivision. The commissioner office shall accept applications after 
7.19 	December 1, 2014, if one of the manufacturers registered before December 1, 2014, ceases 
7.20 	to be registered as a manufacturer. The commissioner's office's determination that no 
7.21 	manufacturer exists to fulfill the duties under sections 152.22 to 152.37 is subject to judicial 
7.22 	review in Ramsey County District Court. Data submitted during the application process are 
7.23 	private data on individuals or nonpublic data as defined in section 13.02 until the 
7.24 	manufacturer is registered under this section. Data on a manufacturer that is registered are 
7.25 	public data, unless the data are trade secret or security information under section 13.37.
7.26 	(b) As a condition for registration, a manufacturer must agree to:
7.27 	(1) begin supplying medical cannabis to patients by July 1, 2015; and
7.28 	(2) comply with all requirements under sections 152.22 to 152.37.
7.29 	(c) The commissioner office shall consider the following factors when determining 
7.30 	which manufacturer to register:
8.1 	(1) the technical expertise of the manufacturer in cultivating medical cannabis and 
8.2 	converting the medical cannabis into an acceptable delivery method under section 152.22, 
8.3 	subdivision 6;
8.4 	(2) the qualifications of the manufacturer's employees;
8.5 	(3) the long-term financial stability of the manufacturer;
8.6 	(4) the ability to provide appropriate security measures on the premises of the 
8.7 	manufacturer;
8.8 	(5) whether the manufacturer has demonstrated an ability to meet the medical cannabis 
8.9 	production needs required by sections 152.22 to 152.37; and
8.10 	(6) the manufacturer's projection and ongoing assessment of fees on patients with a 
8.11 	qualifying medical condition.
8.12 	(d) If an officer, director, or controlling person of the manufacturer pleads or is found 
8.13 	guilty of intentionally diverting medical cannabis to a person other than allowed by law 
8.14 	under section 152.33, subdivision 1, the commissioner office may decide not to renew the 
8.15 	registration of the manufacturer, provided the violation occurred while the person was an 
8.16 	officer, director, or controlling person of the manufacturer.
8.17 	(e) The commissioner office shall require each medical cannabis manufacturer to contract 
8.18 	with an independent laboratory to test medical cannabis produced by the manufacturer. The 
8.19 	commissioner office shall approve the laboratory chosen by each manufacturer and require 
8.20 	that the laboratory report testing results to the manufacturer in a manner determined by the 
8.21 	commissioner office.
8.22 		Subd. 1a.Revocation or nonrenewal of a medical cannabis manufacturer 
8.23 	registration. If the commissioner office intends to revoke or not renew a registration issued 
8.24 	under this section, the commissioner office must first notify in writing the manufacturer 
8.25 	against whom the action is to be taken and provide the manufacturer with an opportunity 
8.26 	to request a hearing under the contested case provisions of chapter 14. If the manufacturer 
8.27 	does not request a hearing by notifying the commissioner office in writing within 20 days 
8.28 	after receipt of the notice of proposed action, the commissioner office may proceed with 
8.29 	the action without a hearing. For revocations, the registration of a manufacturer is considered 
8.30 	revoked on the date specified in the commissioner's office's written notice of revocation.
8.31 		Subd. 1b.Temporary suspension proceedings. The commissioner office may institute 
8.32 	proceedings to temporarily suspend the registration of a medical cannabis manufacturer for 
9.1 	a period of up to 90 days by notifying the manufacturer in writing if any action by an 
9.2 	employee, agent, officer, director, or controlling person of the manufacturer:
9.3 	(1) violates any of the requirements of sections 152.22 to 152.37 or the rules adopted 
9.4 	thereunder;
9.5 	(2) permits, aids, or abets the commission of any violation of state law at the 
9.6 	manufacturer's location for cultivation, harvesting, manufacturing, packaging, and processing 
9.7 	or at any site for distribution of medical cannabis;
9.8 	(3) performs any act contrary to the welfare of a registered patient or registered designated 
9.9 	caregiver; or
9.10 	(4) obtains, or attempts to obtain, a registration by fraudulent means or misrepresentation.
9.11 		Subd. 1c.Notice to patients. Upon the revocation or nonrenewal of a manufacturer's 
9.12 	registration under subdivision 1a or implementation of an enforcement action under 
9.13 	subdivision 1b that may affect the ability of a registered patient, registered designated 
9.14 	caregiver, or a registered patient's parent, legal guardian, or spouse to obtain medical cannabis 
9.15 	from the manufacturer subject to the enforcement action, the commissioner office shall 
9.16 	notify in writing each registered patient and the patient's registered designated caregiver or 
9.17 	registered patient's parent, legal guardian, or spouse about the outcome of the proceeding 
9.18 	and information regarding alternative registered manufacturers. This notice must be provided 
9.19 	two or more business days prior to the effective date of the revocation, nonrenewal, or other 
9.20 	enforcement action.
9.21 		Subd. 2.Range of compounds and dosages; report. The office shall review and publicly 
9.22 	report the existing medical and scientific literature regarding the range of recommended 
9.23 	dosages for each qualifying condition and the range of chemical compositions of any plant 
9.24 	of the genus cannabis that will likely be medically beneficial for each of the qualifying 
9.25 	medical conditions. The office shall make this information available to patients with 
9.26 	qualifying medical conditions beginning December 1, 2014, and update the information 
9.27 	every three years. The office may consult with the independent laboratory under contract 
9.28 	with the manufacturer or other experts in reporting the range of recommended dosages for 
9.29 	each qualifying medical condition, the range of chemical compositions that will likely be 
9.30 	medically beneficial, and any risks of noncannabis drug interactions. The office shall consult 
9.31 	with each manufacturer on an annual basis on medical cannabis offered by the manufacturer. 
9.32 	The list of medical cannabis offered by a manufacturer shall be published on the Office of 
9.33 	Cannabis Management website.
10.1 		Subd. 3.Deadlines.  The commissioner office shall adopt rules necessary for the 
10.2 	manufacturer to begin distribution of medical cannabis to patients under the registry program 
10.3 	by July 1, 2015, and have notice of proposed rules published in the State Register prior to 
10.4 	January 1, 2015.
10.5 		Subd. 4.Reports. (a) The commissioner office shall provide regular updates to the task 
10.6 	force on medical cannabis therapeutic research and to the chairs and ranking minority 
10.7 	members of the legislative committees with jurisdiction over health and human services, 
10.8 	public safety, judiciary, and civil law Cannabis Advisory Council under section 342.03
10.9 	regarding: (1) any changes in federal law or regulatory restrictions regarding the use of 
10.10 	medical cannabis or hemp; and (2) the market demand and supply in this state for products 
10.11 	made from hemp that can be used for medicinal purposes.
10.12 	(b) The commissioner office may submit medical research based on the data collected 
10.13 	under sections 152.22 to 152.37 to any federal agency with regulatory or enforcement 
10.14 	authority over medical cannabis to demonstrate the effectiveness of medical cannabis for 
10.15 	treating a qualifying medical condition.

10.16 	Sec. 10. Minnesota Statutes 2024, section 152.26, is amended to read:
10.17 	152.26 RULEMAKING.
10.18 	(a) The commissioner office may adopt rules to implement sections 152.22 to 152.37. 
10.19 	Rules for which notice is published in the State Register before January 1, 2015, may be 
10.20 	adopted using the process in section 14.389.
10.21 	(b) The commissioner office may adopt or amend rules, using the procedure in section 
10.22 	14.386, paragraph (a), to implement the addition of dried raw cannabis as an allowable form 
10.23 	of medical cannabis under section 152.22, subdivision 6, paragraph (a), clause (4). Section 
10.24 	14.386, paragraph (b), does not apply to these rules.

10.25 	Sec. 11. Minnesota Statutes 2024, section 152.261, is amended to read:
10.26 	152.261 RULES; ADVERSE INCIDENTS.
10.27 	(a) The commissioner of health office shall adopt rules to establish requirements for 
10.28 	reporting incidents when individuals who are not authorized to possess medical cannabis 
10.29 	under sections 152.22 to 152.37 are found in possession of medical cannabis. The rules 
10.30 	must identify professionals required to report, the information they are required to report, 
10.31 	and actions the reporter must take to secure the medical cannabis.
11.1 	(b) The commissioner of health office shall adopt rules to establish requirements for law 
11.2 	enforcement officials and health care professionals to report incidents involving an overdose 
11.3 	of medical cannabis to the commissioner of health office.
11.4 	(c) Rules must include the method by which the commissioner office will collect and 
11.5 	tabulate reports of unauthorized possession and overdose.

11.6 	Sec. 12. Minnesota Statutes 2024, section 152.27, subdivision 2, is amended to read:
11.7 		Subd. 2.Office duties. (a) The office shall:
11.8 	(1) give notice of the program to health care practitioners in the state who are eligible 
11.9 	to serve as health care practitioners and explain the purposes and requirements of the 
11.10 	program;
11.11 	(2) allow each health care practitioner who meets or agrees to meet the program's 
11.12 	requirements and who requests to participate, to be included in the registry program to 
11.13 	collect data for the patient registry;
11.14 	(3) provide explanatory information and assistance to each health care practitioner in 
11.15 	understanding the nature of therapeutic use of medical cannabis within program requirements;
11.16 	(4) create and provide a certification to be used by a health care practitioner for the 
11.17 	practitioner to certify whether a patient has been diagnosed with a qualifying medical 
11.18 	condition;
11.19 	(5) supervise the participation of the health care practitioner in conducting patient 
11.20 	treatment and health records reporting in a manner that ensures stringent security and 
11.21 	record-keeping requirements and that prevents the unauthorized release of private data on 
11.22 	individuals as defined by section 13.02;
11.23 	(6) develop safety criteria for patients with a qualifying medical condition as a 
11.24 	requirement of the patient's participation in the program, to prevent the patient from 
11.25 	undertaking any task under the influence of medical cannabis that would constitute negligence 
11.26 	or professional malpractice on the part of the patient; and
11.27 	(7) conduct research and studies based on data from health records submitted to the 
11.28 	registry program and submit reports on intermediate or final research results to the legislature 
11.29 	and major scientific journals. The office may contract with a third party to complete the 
11.30 	requirements of this clause. Any reports submitted must comply with section 152.28, 
11.31 	subdivision 2.
12.1 	(b) The office may add a delivery method under section 152.22, subdivision 6, upon a 
12.2 	petition from a member of the public or the Cannabis Advisory Council under section 342.03
12.3 	or as directed by law. If the office wishes to add a delivery method under section 152.22, 
12.4 	subdivision 6, the office must notify the chairs and ranking minority members of the 
12.5 	legislative policy committees having jurisdiction over health and public safety of the addition 
12.6 	and the reasons for its addition, including any written comments received by the office from 
12.7 	the public and any guidance received from the Cannabis Advisory Council under section 
12.8 	342.03, by January 15 of the year in which the office wishes to make the change. The change 
12.9 	shall be effective on August 1 of that year, unless the legislature by law provides otherwise.

12.10 	Sec. 13. Minnesota Statutes 2024, section 152.27, subdivision 7, is amended to read:
12.11 		Subd. 7.Notice requirements. Patients and registered designated caregivers shall notify 
12.12 	the commissioner office of any address or name change within 30 days of the change having 
12.13 	occurred. A patient or registered designated caregiver is subject to a $100 fine for failure 
12.14 	to notify the commissioner office of the change.

12.15 	Sec. 14. Minnesota Statutes 2024, section 152.28, subdivision 1, is amended to read:
12.16 		Subdivision 1.Health care practitioner duties. (a) Prior to a patient's enrollment in 
12.17 	the registry program, a health care practitioner shall:
12.18 	(1) determine, in the health care practitioner's medical judgment, whether a patient suffers 
12.19 	from a qualifying medical condition, and, if so determined, provide the patient with a 
12.20 	certification of that diagnosis;
12.21 	(2) advise patients, registered designated caregivers, and parents, legal guardians, or 
12.22 	spouses who are acting as caregivers of the existence of any nonprofit patient support groups 
12.23 	or organizations;
12.24 	(3) provide explanatory information from the office to patients with qualifying medical 
12.25 	conditions, including disclosure to all patients about the experimental nature of therapeutic 
12.26 	use of medical cannabis; the possible risks, benefits, and side effects of the proposed 
12.27 	treatment; the application and other materials from the office; and provide patients with the 
12.28 	Tennessen warning as required by section 13.04, subdivision 2; and
12.29 	(4) agree to continue treatment of the patient's qualifying medical condition and report 
12.30 	medical findings to the office.
12.31 	(b) Upon notification from the office of the patient's enrollment in the registry program, 
12.32 	the health care practitioner shall:
13.1 	(1) participate in the patient registry reporting system under the guidance and supervision 
13.2 	of the office;
13.3 	(2) report health records of the patient throughout the ongoing treatment of the patient 
13.4 	to the office in a manner determined by the commissioner office and in accordance with 
13.5 	subdivision 2;
13.6 	(3) determine, every three years, if the patient continues to suffer from a qualifying 
13.7 	medical condition and, if so, issue the patient a new certification of that diagnosis; and
13.8 	(4) otherwise comply with all requirements developed by the office.
13.9 	(c) A health care practitioner may utilize telehealth, as defined in section 62A.673, 
13.10 	subdivision 2, for certifications and recertifications.
13.11 	(d) Nothing in this section requires a health care practitioner to participate in the registry 
13.12 	program.

13.13 	Sec. 15. Minnesota Statutes 2024, section 152.28, subdivision 3, is amended to read:
13.14 		Subd. 3.Advertising restrictions. (a) A health care practitioner shall not publish or 
13.15 	cause to be published any advertisement that:
13.16 	(1) contains false or misleading statements about medical cannabis or about the medical 
13.17 	cannabis registry program;
13.18 	(2) uses colloquial terms to refer to medical cannabis, such as pot, weed, or grass;
13.19 	(3) states or implies the health care practitioner is endorsed by the Department of Health
13.20 	office or by the medical cannabis registry program;
13.21 	(4) includes images of cannabis in its plant or leaf form or of cannabis-smoking 
13.22 	paraphernalia; or
13.23 	(5) contains medical symbols that could reasonably be confused with symbols of 
13.24 	established medical associations or groups.
13.25 	(b) A health care practitioner found by the commissioner office to have violated this 
13.26 	subdivision is prohibited from certifying that patients have a qualifying medical condition 
13.27 	for purposes of patient participation in the registry program. The commissioner's office's
13.28 	decision that a health care practitioner has violated this subdivision is a final decision of 
13.29 	the commissioner office and is not subject to the contested case procedures in chapter 14.

14.1 	Sec. 16. Minnesota Statutes 2024, section 152.29, subdivision 1, is amended to read:
14.2 		Subdivision 1.Manufacturer; requirements. (a) A manufacturer may operate eight 
14.3 	distribution facilities, which may include the manufacturer's single location for cultivation, 
14.4 	harvesting, manufacturing, packaging, and processing but is not required to include that 
14.5 	location. The commissioner office shall designate the geographical service areas to be served 
14.6 	by each manufacturer based on geographical need throughout the state to improve patient 
14.7 	access. A manufacturer shall not have more than two distribution facilities in each 
14.8 	geographical service area assigned to the manufacturer by the commissioner office. A 
14.9 	manufacturer shall operate only one location where all cultivation, harvesting, manufacturing, 
14.10 	packaging, and processing of medical cannabis shall be conducted. This location may be 
14.11 	one of the manufacturer's distribution facility sites. The additional distribution facilities 
14.12 	may dispense medical cannabis and medical cannabis products but may not contain any 
14.13 	medical cannabis in a form other than those forms allowed under section 152.22, subdivision 
14.14 	6, and the manufacturer shall not conduct any cultivation, harvesting, manufacturing, 
14.15 	packaging, or processing at the other distribution facility sites. Any distribution facility 
14.16 	operated by the manufacturer is subject to all of the requirements applying to the 
14.17 	manufacturer under sections 152.22 to 152.37, including, but not limited to, security and 
14.18 	distribution requirements.
14.19 	(b) A manufacturer may acquire hemp grown in this state from a hemp grower, and may 
14.20 	acquire hemp products produced by a hemp processor. A manufacturer may manufacture 
14.21 	or process hemp and hemp products into an allowable form of medical cannabis under 
14.22 	section 152.22, subdivision 6. Hemp and hemp products acquired by a manufacturer under 
14.23 	this paragraph are subject to the same quality control program, security and testing 
14.24 	requirements, and other requirements that apply to medical cannabis under sections 152.22 
14.25 	to 152.37 and Minnesota Rules, chapter 4770.
14.26 	(c) A medical cannabis manufacturer shall contract with a laboratory approved by the 
14.27 	commissioner office, subject to any additional requirements set by the commissioner office, 
14.28 	for purposes of testing medical cannabis manufactured or hemp or hemp products acquired 
14.29 	by the medical cannabis manufacturer as to content, contamination, and consistency to 
14.30 	verify the medical cannabis meets the requirements of section 152.22, subdivision 6. The 
14.31 	cost of laboratory testing shall be paid by the manufacturer.
14.32 	(d) The operating documents of a manufacturer must include:
14.33 	(1) procedures for the oversight of the manufacturer and procedures to ensure accurate 
14.34 	record keeping;
15.1 	(2) procedures for the implementation of appropriate security measures to deter and 
15.2 	prevent the theft of medical cannabis and unauthorized entrance into areas containing medical 
15.3 	cannabis; and
15.4 	(3) procedures for the delivery and transportation of hemp between hemp growers and 
15.5 	manufacturers and for the delivery and transportation of hemp products between hemp 
15.6 	processors and manufacturers.
15.7 	(e) A manufacturer shall implement security requirements, including requirements for 
15.8 	the delivery and transportation of hemp and hemp products, protection of each location by 
15.9 	a fully operational security alarm system, facility access controls, perimeter intrusion 
15.10 	detection systems, and a personnel identification system.
15.11 	(f) A manufacturer shall not share office space with, refer patients to a health care 
15.12 	practitioner, or have any financial relationship with a health care practitioner.
15.13 	(g) A manufacturer shall not permit any person to consume medical cannabis on the 
15.14 	property of the manufacturer.
15.15 	(h) A manufacturer is subject to reasonable inspection by the commissioner office.
15.16 	(i) For purposes of sections 152.22 to 152.37, a medical cannabis manufacturer is not 
15.17 	subject to the Board of Pharmacy licensure or regulatory requirements under chapter 151.
15.18 	(j) A medical cannabis manufacturer may not employ any person who is under 21 years 
15.19 	of age or who has been convicted of a disqualifying felony offense. An employee of a 
15.20 	medical cannabis manufacturer must submit a completed criminal history records check 
15.21 	consent form, a full set of classifiable fingerprints, and the required fees for submission to 
15.22 	the Bureau of Criminal Apprehension before an employee may begin working with the 
15.23 	manufacturer. The bureau must conduct a Minnesota criminal history records check and 
15.24 	the superintendent is authorized to exchange the fingerprints with the Federal Bureau of 
15.25 	Investigation to obtain the applicant's national criminal history record information. The 
15.26 	bureau shall return the results of the Minnesota and federal criminal history records checks 
15.27 	to the commissioner office.
15.28 	(k) A manufacturer may not operate in any location, whether for distribution or 
15.29 	cultivation, harvesting, manufacturing, packaging, or processing, within 1,000 feet of a 
15.30 	public or private school existing before the date of the manufacturer's registration with the 
15.31 	commissioner office.
15.32 	(l) A manufacturer shall comply with reasonable restrictions set by the commissioner
15.33 	office relating to signage, marketing, display, and advertising of medical cannabis.
16.1 	(m) Before a manufacturer acquires hemp from a hemp grower or hemp products from 
16.2 	a hemp processor, the manufacturer must verify that the hemp grower or hemp processor 
16.3 	has a valid license issued by the commissioner of agriculture under chapter 18K.
16.4 	(n) Until a state-centralized, seed-to-sale system is implemented that can track a specific 
16.5 	medical cannabis plant from cultivation through testing and point of sale, the commissioner
16.6 	office shall conduct at least one unannounced inspection per year of each manufacturer that 
16.7 	includes inspection of:
16.8 	(1) business operations;
16.9 	(2) physical locations of the manufacturer's manufacturing facility and distribution 
16.10 	facilities;
16.11 	(3) financial information and inventory documentation, including laboratory testing 
16.12 	results; and
16.13 	(4) physical and electronic security alarm systems.

16.14 	Sec. 17. Minnesota Statutes 2024, section 152.29, subdivision 2, is amended to read:
16.15 		Subd. 2.Manufacturer; production. (a) A manufacturer of medical cannabis shall 
16.16 	provide a reliable and ongoing supply of all medical cannabis needed for the registry program 
16.17 	through cultivation by the manufacturer and through the purchase of hemp from hemp 
16.18 	growers.
16.19 	(b) All cultivation, harvesting, manufacturing, packaging, and processing of medical 
16.20 	cannabis must take place in an enclosed, locked facility at a physical address provided to 
16.21 	the commissioner office during the registration process.
16.22 	(c) A manufacturer must process and prepare any medical cannabis plant material or 
16.23 	hemp plant material into a form allowable under section 152.22, subdivision 6, prior to 
16.24 	distribution of any medical cannabis.

16.25 	Sec. 18. Minnesota Statutes 2024, section 152.29, subdivision 3a, is amended to read:
16.26 		Subd. 3a.Transportation of medical cannabis; transport staffing. (a) A medical 
16.27 	cannabis manufacturer may staff a transport motor vehicle with only one employee if the 
16.28 	medical cannabis manufacturer is transporting medical cannabis to either a certified 
16.29 	laboratory for the purpose of testing or a facility for the purpose of disposal. If the medical 
16.30 	cannabis manufacturer is transporting medical cannabis for any other purpose or destination, 
17.1 	the transport motor vehicle must be staffed with a minimum of two employees as required 
17.2 	by rules adopted by the commissioner office.
17.3 	(b) Notwithstanding paragraph (a), a medical cannabis manufacturer that is only 
17.4 	transporting hemp for any purpose may staff the transport motor vehicle with only one 
17.5 	employee.
17.6 	(c) A medical cannabis manufacturer may contract with a third party for armored car 
17.7 	services for deliveries of medical cannabis from its production facility to distribution 
17.8 	facilities. A medical cannabis manufacturer that contracts for armored car services remains 
17.9 	responsible for the transportation manifest and inventory tracking requirements in rules 
17.10 	adopted by the commissioner office.
17.11 	(d) Department of Health Office staff may transport medical cannabis for the purposes 
17.12 	of delivering medical cannabis and other samples to a laboratory for testing under rules 
17.13 	adopted by the commissioner office and in cases of special investigations when the 
17.14 	commissioner office has determined there is a potential threat to public health. The transport 
17.15 	motor vehicle must be staffed with a minimum of two Department of Health office
17.16 	employees. The employees must carry with them their Department of Health office
17.17 	identification card and a transport manifest.

17.18 	Sec. 19. Minnesota Statutes 2024, section 152.29, subdivision 4, is amended to read:
17.19 		Subd. 4.Report. (a) Each manufacturer shall report to the commissioner office on a 
17.20 	monthly basis the following information on each individual patient for the month prior to 
17.21 	the report:
17.22 	(1) the amount and dosages of medical cannabis distributed;
17.23 	(2) the chemical composition of the medical cannabis; and
17.24 	(3) the tracking number assigned to any medical cannabis distributed.
17.25 	(b) For transactions involving Tribal medical cannabis program patients, each 
17.26 	manufacturer shall report to the commissioner office on a weekly basis the following 
17.27 	information on each individual Tribal medical cannabis program patient for the week prior 
17.28 	to the report:
17.29 	(1) the name of the Tribal medical cannabis program in which the Tribal medical cannabis 
17.30 	program patient is enrolled;
17.31 	(2) the amount and dosages of medical cannabis distributed;
17.32 	(3) the chemical composition of the medical cannabis distributed; and
18.1 	(4) the tracking number assigned to the medical cannabis distributed.

18.2 	Sec. 20. Minnesota Statutes 2024, section 152.31, is amended to read:
18.3 	152.31 DATA PRACTICES.
18.4 	(a) Government data in patient files maintained by the commissioner office and the 
18.5 	health care practitioner, and data submitted to or by a medical cannabis manufacturer, are 
18.6 	private data on individuals, as defined in section 13.02, subdivision 12, or nonpublic data, 
18.7 	as defined in section 13.02, subdivision 9, but may be used for purposes of complying with 
18.8 	chapter 13 and complying with a request from the legislative auditor or the state auditor in 
18.9 	the performance of official duties. The provisions of section 13.05, subdivision 11, apply 
18.10 	to a registration agreement entered between the commissioner office and a medical cannabis 
18.11 	manufacturer under section 152.25.
18.12 	(b) Not public data maintained by the commissioner office may not be used for any 
18.13 	purpose not provided for in sections 152.22 to 152.37, and may not be combined or linked 
18.14 	in any manner with any other list, dataset, or database.
18.15 	(c) The commissioner office may execute data sharing arrangements with the 
18.16 	commissioner of agriculture to verify licensing, inspection, and compliance information 
18.17 	related to hemp growers and hemp processors under chapter 18K.

18.18 	Sec. 21. Minnesota Statutes 2024, section 152.32, subdivision 2, is amended to read:
18.19 		Subd. 2.Criminal and civil protections. (a) Subject to section 152.23, the following 
18.20 	are not violations under this chapter:
18.21 	(1) use or possession of medical cannabis or medical cannabis products by a patient 
18.22 	enrolled in the registry program; possession by a registered designated caregiver or the 
18.23 	parent, legal guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed 
18.24 	on the registry verification; or use or possession of medical cannabis or medical cannabis 
18.25 	products by a Tribal medical cannabis program patient;
18.26 	(2) possession, dosage determination, or sale of medical cannabis or medical cannabis 
18.27 	products by a medical cannabis manufacturer, employees of a manufacturer, a Tribal medical 
18.28 	cannabis program manufacturer, employees of a Tribal medical cannabis program 
18.29 	manufacturer, a laboratory conducting testing on medical cannabis, or employees of the 
18.30 	laboratory; and
18.31 	(3) possession of medical cannabis or medical cannabis products by any person while 
18.32 	carrying out the duties required under sections 152.22 to 152.37.
19.1 	(b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and 
19.2 	associated property is not subject to forfeiture under sections 609.531 to 609.5316.
19.3 	(c) The commissioner office, members of a Tribal medical cannabis board, the 
19.4 	commissioner's office's or Tribal medical cannabis board's staff, the commissioner's office's
19.5 	or Tribal medical cannabis board's agents or contractors, and any health care practitioner 
19.6 	are not subject to any civil or disciplinary penalties by the Board of Medical Practice, the 
19.7 	Board of Nursing, or by any business, occupational, or professional licensing board or entity, 
19.8 	solely for participation in the registry program under sections 152.22 to 152.37 or in a Tribal 
19.9 	medical cannabis program. A pharmacist licensed under chapter 151 is not subject to any 
19.10 	civil or disciplinary penalties by the Board of Pharmacy when acting in accordance with 
19.11 	the provisions of sections 152.22 to 152.37. Nothing in this section affects a professional 
19.12 	licensing board from taking action in response to violations of any other section of law.
19.13 	(d) Notwithstanding any law to the contrary, the commissioner office, the governor of 
19.14 	Minnesota, or an employee of any state agency may not be held civilly or criminally liable 
19.15 	for any injury, loss of property, personal injury, or death caused by any act or omission 
19.16 	while acting within the scope of office or employment under sections 152.22 to 152.37.
19.17 	(e) Federal, state, and local law enforcement authorities are prohibited from accessing 
19.18 	the patient registry under sections 152.22 to 152.37 except when acting pursuant to a valid 
19.19 	search warrant.
19.20 	(f) Notwithstanding any law to the contrary, neither the commissioner office nor a public 
19.21 	employee may release data or information about an individual contained in any report, 
19.22 	document, or registry created under sections 152.22 to 152.37 or any information obtained 
19.23 	about a patient participating in the program, except as provided in sections 152.22 to 152.37.
19.24 	(g) No information contained in a report, document, or registry or obtained from a patient 
19.25 	under sections 152.22 to 152.37 or from a Tribal medical cannabis program patient may be 
19.26 	admitted as evidence in a criminal proceeding unless independently obtained or in connection 
19.27 	with a proceeding involving a violation of sections 152.22 to 152.37.
19.28 	(h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty 
19.29 	of a gross misdemeanor.
19.30 	(i) An attorney may not be subject to disciplinary action by the Minnesota Supreme 
19.31 	Court, a Tribal court, or the professional responsibility board for providing legal assistance 
19.32 	to prospective or registered manufacturers or others related to activity that is no longer 
19.33 	subject to criminal penalties under state law pursuant to sections 152.22 to 152.37, or for 
20.1 	providing legal assistance to a Tribal medical cannabis program or a Tribal medical cannabis 
20.2 	program manufacturer.
20.3 	(j) The following do not constitute probable cause or reasonable suspicion, and shall not 
20.4 	be used to support a search of the person or property of the person possessing or applying 
20.5 	for the registry verification or equivalent, or otherwise subject the person or property of the 
20.6 	person to inspection by any governmental agency:
20.7 	(1) possession of a registry verification or application for enrollment in the registry 
20.8 	program by a person entitled to possess a registry verification or apply for enrollment in 
20.9 	the registry program; or
20.10 	(2) possession of a verification or equivalent issued by a Tribal medical cannabis program 
20.11 	or application for enrollment in a Tribal medical cannabis program by a person entitled to 
20.12 	possess such a verification or application.

20.13 	Sec. 22. Minnesota Statutes 2024, section 152.33, subdivision 1a, is amended to read:
20.14 		Subd. 1a.Intentional diversion outside the state; penalties. (a) In addition to any other 
20.15 	applicable penalty in law, the commissioner office may levy a fine of $250,000 against a 
20.16 	manufacturer and may immediately initiate proceedings to revoke the manufacturer's 
20.17 	registration, using the procedure in section 152.25, if:
20.18 	(1) an officer, director, or controlling person of the manufacturer pleads or is found 
20.19 	guilty under subdivision 1 of intentionally transferring medical cannabis, while the person 
20.20 	was an officer, director, or controlling person of the manufacturer, to a person other than 
20.21 	allowed by law; and
20.22 	(2) in intentionally transferring medical cannabis to a person other than allowed by law, 
20.23 	the officer, director, or controlling person transported or directed the transport of medical 
20.24 	cannabis outside of Minnesota.
20.25 	(b) All fines collected under this subdivision shall be deposited in the state government 
20.26 	special revenue fund.

20.27 	Sec. 23. Minnesota Statutes 2024, section 152.33, subdivision 4, is amended to read:
20.28 		Subd. 4.Submission of false records; criminal penalty. A person who knowingly 
20.29 	submits false records or documentation required by the commissioner office to register as 
20.30 	a manufacturer of medical cannabis under sections 152.22 to 152.37 is guilty of a felony 
20.31 	and may be sentenced to imprisonment for not more than two years or by payment of a fine 
20.32 	of not more than $3,000, or both.

21.1 	Sec. 24. Minnesota Statutes 2024, section 152.35, is amended to read:
21.2 	152.35 FEES; DEPOSIT OF REVENUE.
21.3 	(a) The commissioner office shall collect an application fee of $20,000 from each entity 
21.4 	submitting an application for registration as a medical cannabis manufacturer. Revenue 
21.5 	from the fee shall be deposited in the state treasury and credited to the state government 
21.6 	special revenue fund.
21.7 	(b) The commissioner office shall establish and collect an annual fee from a medical 
21.8 	cannabis manufacturer equal to the cost of regulating and inspecting the manufacturer in 
21.9 	that year. Revenue from the fee amount shall be deposited in the state treasury and credited 
21.10 	to the state government special revenue fund.
21.11 	(c) A medical cannabis manufacturer may charge patients enrolled in the registry program 
21.12 	a reasonable fee for costs associated with the operations of the manufacturer. The 
21.13 	manufacturer may establish a sliding scale of patient fees based upon a patient's household 
21.14 	income and may accept private donations to reduce patient fees.

21.15 	Sec. 25. Minnesota Statutes 2024, section 152.37, is amended to read:
21.16 	152.37 FINANCIAL EXAMINATIONS; PRICING REVIEWS.
21.17 		Subdivision 1.Financial records. A medical cannabis manufacturer shall maintain 
21.18 	detailed financial records in a manner and format approved by the commissioner office, 
21.19 	and shall keep all records updated and accessible to the commissioner office when requested.
21.20 		Subd. 2.Certified annual audit. A medical cannabis manufacturer shall submit the 
21.21 	results of an annual certified financial audit to the commissioner office no later than May 
21.22 	1 of each year for the calendar year beginning January 2015. The annual audit shall be 
21.23 	conducted by an independent certified public accountant and the costs of the audit are the 
21.24 	responsibility of the medical cannabis manufacturer. Results of the audit shall be provided 
21.25 	to the medical cannabis manufacturer and the commissioner office. The commissioner office
21.26 	may also require another audit of the medical cannabis manufacturer by a certified public 
21.27 	accountant chosen by the commissioner office with the costs of the audit paid by the medical 
21.28 	cannabis manufacturer.
21.29 		Subd. 3.Power to examine. (a) The commissioner office or designee may examine the 
21.30 	business affairs and conditions of any medical cannabis manufacturer, including but not 
21.31 	limited to a review of the financing, budgets, revenues, sales, and pricing.
22.1 	(b) An examination may cover the medical cannabis manufacturer's business affairs, 
22.2 	practices, and conditions including but not limited to a review of the financing, budgets, 
22.3 	revenues, sales, and pricing. The commissioner office shall determine the nature and scope 
22.4 	of each examination and in doing so shall take into account all available relevant factors 
22.5 	concerning the financial and business affairs, practices, and conditions of the examinee. 
22.6 	The costs incurred by the department in conducting an examination shall be paid for by the 
22.7 	medical cannabis manufacturer.
22.8 	(c) When making an examination under this section, the commissioner office may retain 
22.9 	attorneys, appraisers, independent economists, independent certified public accountants, or 
22.10 	other professionals and specialists as designees. A certified public accountant retained by 
22.11 	the commissioner office may not be the same certified public accountant providing the 
22.12 	certified annual audit in subdivision 2.
22.13 	(d) The commissioner office shall make a report of an examination conducted under this 
22.14 	section and provide a copy to the medical cannabis manufacturer. The commissioner office
22.15 	shall then post a copy of the report on the department's website. All working papers, recorded 
22.16 	information, documents, and copies produced by, obtained by, or disclosed to the 
22.17 	commissioner office or any other person in the course of an examination, other than the 
22.18 	information contained in any commissioner office official report, made under this section 
22.19 	are private data on individuals or nonpublic data, as defined in section 13.02.

22.20 	Sec. 26. Minnesota Statutes 2024, section 342.01, subdivision 9, is amended to read:
22.21 		Subd. 9.Bona fide labor organization. "Bona fide labor organization" means a labor 
22.22 	union that represents or is actively seeking to represent cannabis workers. of:
22.23 	(1) a cannabis business; or
22.24 	(2) a lower-potency hemp edible manufacturer.

22.25 	Sec. 27. Minnesota Statutes 2024, section 342.01, subdivision 34, is amended to read:
22.26 		Subd. 34.Hemp business. (a) "Hemp business" means either any of the following 
22.27 	licensed under this chapter:
22.28 	(1) lower-potency hemp edible manufacturer; or
22.29 	(2) lower-potency hemp edible wholesaler; or
22.30 	(2) (3) lower-potency hemp edible retailer.
23.1 	(b) Hemp business does not include a person or entity licensed under chapter 18K to 
23.2 	grow industrial hemp for commercial or research purposes or to process industrial hemp 
23.3 	for commercial purposes.

23.4 	Sec. 28. Minnesota Statutes 2024, section 342.01, subdivision 47, is amended to read:
23.5 		Subd. 47.Labor peace agreement. "Labor peace agreement" means an agreement 
23.6 	between a cannabis business and a bona fide labor organization or an agreement between 
23.7 	a lower-potency hemp edible manufacturer and a bona fide labor organization that protects 
23.8 	the state's interests by, at minimum, prohibiting the labor organization from engaging in 
23.9 	picketing, work stoppages, or boycotts against the cannabis business or lower-potency hemp 
23.10 	edible manufacturer.

23.11 	Sec. 29. Minnesota Statutes 2024, section 342.01, subdivision 48, is amended to read:
23.12 		Subd. 48.License holder. "License holder" means a person, cooperative, or business 
23.13 	that holds any of the following licenses:
23.14 	(1) cannabis microbusiness;
23.15 	(2) cannabis mezzobusiness;
23.16 	(3) cannabis cultivator;
23.17 	(4) cannabis manufacturer;
23.18 	(5) cannabis retailer;
23.19 	(6) cannabis wholesaler;
23.20 	(7) cannabis transporter;
23.21 	(8) cannabis testing facility;
23.22 	(9) cannabis event organizer;
23.23 	(10) cannabis delivery service;
23.24 	(11) lower-potency hemp edible manufacturer;
23.25 	(12) lower-potency hemp edible wholesaler;
23.26 	(12) (13) lower-potency hemp edible retailer; or
23.27 	(13) (14) medical cannabis combination business.

24.1 	Sec. 30. Minnesota Statutes 2024, section 342.01, subdivision 50, is amended to read:
24.2 		Subd. 50.Lower-potency hemp edible. (a) "Lower-potency hemp edible" means any 
24.3 	product that:
24.4 	(1) is intended to be eaten or consumed as a beverage by humans;
24.5 	(2) contains hemp concentrate or an artificially derived cannabinoid, in combination 
24.6 	with food ingredients;
24.7 	(3) is not a drug;
24.8 	(4) does not contain a cannabinoid derived from cannabis plants or cannabis flower;
24.9 	(5) is a type of product approved for sale by the office or is substantially similar to a 
24.10 	product approved by the office, including but not limited to products that resemble 
24.11 	nonalcoholic beverages, candy, and baked goods; and
24.12 	(6) meets either of the requirements in paragraph (b).
24.13 	(b) A lower-potency hemp edible includes:
24.14 	(1) a product that:
24.15 	(i) is not intended to be consumed as a beverage and consists of servings that contain 
24.16 	no more than five milligrams of delta-9 tetrahydrocannabinol; is intended to be consumed 
24.17 	as a beverage and contains no more than ten milligrams of delta-9 tetrahydrocannabinol in 
24.18 	a single container; is intended to be consumed in any approved manner and consists of 
24.19 	servings or a container that contain no more than 25 100 milligrams of cannabidiol, 
24.20 	cannabigerol, cannabinol, or cannabichromene; is intended to be consumed in any approved 
24.21 	manner and contains no more than the established limit of any other cannabinoid authorized 
24.22 	by the office; or is intended to be consumed in any approved manner and contains any 
24.23 	combination of those cannabinoids that does not exceed the identified amounts for the 
24.24 	applicable product category;
24.25 	(ii) does not contain more than a combined total of 0.5 milligrams of all other 
24.26 	cannabinoids per serving; and
24.27 	(iii) does not contain an artificially derived cannabinoid other than delta-9 
24.28 	tetrahydrocannabinol, except that a product may include artificially derived cannabinoids 
24.29 	created during the process of creating the delta-9 tetrahydrocannabinol that is added to the 
24.30 	product, if no artificially derived cannabinoid is added to the ingredient containing delta-9 
24.31 	tetrahydrocannabinol and the ratio of delta-9 tetrahydrocannabinol to all other artificially 
24.32 	derived cannabinoids is no less than 20 to one; or
25.1 	(2) a product that:
25.2 	(i) contains hemp concentrate processed or refined without increasing the percentage of 
25.3 	targeted cannabinoids or altering the ratio of cannabinoids in the extracts or resins of a hemp 
25.4 	plant or hemp plant parts beyond the variability generally recognized for the method used 
25.5 	for processing or refining or by an amount needed to reduce the total THC in the hemp 
25.6 	concentrate; and
25.7 	(ii) consists of servings that contain no more than five milligrams of total THC.

25.8 	Sec. 31. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
25.9 	read:
25.10 		Subd. 54a.Medical cannabis paraphernalia. "Medical cannabis paraphernalia" means 
25.11 	a delivery device, related supply, or educational material used by a patient enrolled in the 
25.12 	registry program to administer medical cannabis and medical cannabinoid products.

25.13 	Sec. 32. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
25.14 	read:
25.15 		Subd. 69c.Tribal medical cannabis board. "Tribal medical cannabis board" means an 
25.16 	agency established by a federally recognized Tribal government and authorized by the 
25.17 	Tribe's governing body to provide regulatory oversight and monitor compliance with a 
25.18 	Tribal medical cannabis program and applicable regulations.

25.19 	Sec. 33. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
25.20 	read:
25.21 		Subd. 69d.Tribal medical cannabis program. "Tribal medical cannabis program" 
25.22 	means a program established by a federally recognized Tribal government within the 
25.23 	boundaries of Minnesota that involves the commercial production, processing, sale or 
25.24 	distribution, and possession of medical cannabis and medical cannabis products.

25.25 	Sec. 34. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to 
25.26 	read:
25.27 		Subd. 69e.Tribal medical cannabis program patient. "Tribal medical cannabis program 
25.28 	patient" means a person who possesses a valid registration verification card or equivalent 
25.29 	document that is issued under the laws or regulations of a Tribal Nation within the boundaries 
25.30 	of Minnesota. A valid registration verification card must verify that the card holder is 
25.31 	enrolled in or authorized to participate in a Tribal medical cannabis program.

26.1 	Sec. 35. Minnesota Statutes 2024, section 342.01, subdivision 71, is amended to read:
26.2 		Subd. 71.Visiting patient. "Visiting patient" means an individual who is not a Minnesota 
26.3 	resident and who possesses a valid registration verification card or its equivalent that is 
26.4 	issued under the laws or regulations of another state, district, commonwealth, or territory 
26.5 	of the United States verifying that the individual is enrolled in or authorized to participate 
26.6 	in that jurisdiction's medical cannabis or medical marijuana program or in a Tribal medical 
26.7 	cannabis program.

26.8 	Sec. 36. Minnesota Statutes 2024, section 342.02, subdivision 3, is amended to read:
26.9 		Subd. 3.Medical cannabis program. (a) The powers and duties of the Department of 
26.10 	Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections 
26.11 	152.22 to 152.37, are transferred to the Office of Cannabis Management under section 
26.12 	15.039.
26.13 	(b) The following protections shall apply to employees who are transferred from the 
26.14 	Department of Health to the Office of Cannabis Management:
26.15 	(1) the employment status and job classification of a transferred employee shall not be 
26.16 	altered as a result of the transfer;
26.17 	(2) transferred employees who were represented by an exclusive representative prior to 
26.18 	the transfer shall continue to be represented by the same exclusive representative after the 
26.19 	transfer;
26.20 	(3) the applicable collective bargaining agreements with exclusive representatives shall 
26.21 	continue in full force and effect for such transferred employees after the transfer;
26.22 	(4) the state must meet and negotiate with the exclusive representatives of the transferred 
26.23 	employees about any proposed changes affecting or relating to the transferred employees' 
26.24 	terms and conditions of employment to the extent such changes are not addressed in the 
26.25 	applicable collective bargaining agreement; and
26.26 	(5) for an employee in a temporary unclassified position transferred to the Office of 
26.27 	Cannabis Management, the total length of time that the employee has served in the 
26.28 	appointment shall include all time served in the appointment and the transferring agency 
26.29 	and the time served in the appointment at the Office of Cannabis Management. An employee 
26.30 	in a temporary unclassified position who was hired by a transferring agency through an 
26.31 	open competitive selection process in accordance with a policy enacted by Minnesota 
26.32 	Management and Budget shall be considered to have been hired through such process after 
26.33 	the transfer.
27.1 	(c) This subdivision is effective July 1, 2024.

27.2 	Sec. 37. Minnesota Statutes 2024, section 342.09, subdivision 2, is amended to read:
27.3 		Subd. 2.Home cultivation of cannabis for personal adult use. (a) Up to eight cannabis 
27.4 	plants, with no more than four being mature, flowering plants may be grown at a single 
27.5 	residence, including the curtilage or yard, without a license to cultivate cannabis issued 
27.6 	under this chapter provided that cultivation takes place at the primary residence of an 
27.7 	individual 21 years of age or older and in an enclosed, locked space that is not open to public 
27.8 	view.
27.9 	(b) Pursuant to section 342.52, subdivision 9, paragraph (d), a registered designated 
27.10 	caregiver may cultivate up to eight cannabis plants for not more than one patient household. 
27.11 	In addition to eight cannabis plants for one patient household, a registered designated 
27.12 	caregiver may cultivate up to eight cannabis plants for the caregiver's personal adult use of 
27.13 	cannabis. Of the 16 or fewer total cannabis plants being grown in the registered caregiver's 
27.14 	residence, no more than eight may be mature, flowering plants.

27.15 	Sec. 38. Minnesota Statutes 2024, section 342.10, is amended to read:
27.16 	342.10 LICENSES; TYPES.
27.17 	The office shall issue the following types of license:
27.18 	(1) cannabis microbusiness;
27.19 	(2) cannabis mezzobusiness;
27.20 	(3) cannabis cultivator;
27.21 	(4) cannabis manufacturer;
27.22 	(5) cannabis retailer;
27.23 	(6) cannabis wholesaler;
27.24 	(7) cannabis transporter;
27.25 	(8) cannabis testing facility;
27.26 	(9) cannabis event organizer;
27.27 	(10) cannabis delivery service;
27.28 	(11) lower-potency hemp edible manufacturer;
27.29 	(12) lower-potency hemp edible wholesaler;
28.1 	(12) (13) lower-potency hemp edible retailer; and
28.2 	(13) (14) medical cannabis combination business.

28.3 	Sec. 39. Minnesota Statutes 2024, section 342.11, is amended to read:
28.4 	342.11 LICENSES; FEES.
28.5 	(a) The office shall require the payment of application fees, initial licensing fees, and 
28.6 	renewal licensing fees as provided in this section. The initial license fee shall include the 
28.7 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
28.8 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
28.9 	Nothing in this section prohibits a local unit of government from charging the retailer 
28.10 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
28.11 	renewal licensing fees are nonrefundable.
28.12 	(b) Application and licensing fees shall be as follows:
28.13 	(1) for a cannabis microbusiness:
28.14 	(i) an application fee of $500;
28.15 	(ii) an initial license fee of $0; and
28.16 	(iii) a renewal license fee of $2,000;
28.17 	(2) for a cannabis mezzobusiness:
28.18 	(i) an application fee of $5,000;
28.19 	(ii) an initial license fee of $5,000; and
28.20 	(iii) a renewal license fee of $10,000;
28.21 	(3) for a cannabis cultivator:
28.22 	(i) an application fee of $10,000;
28.23 	(ii) an initial license fee of $20,000; and
28.24 	(iii) a renewal license fee of $30,000;
28.25 	(4) for a cannabis manufacturer:
28.26 	(i) an application fee of $10,000;
28.27 	(ii) an initial license fee of $10,000; and
28.28 	(iii) a renewal license fee of $20,000;
29.1 	(5) for a cannabis retailer:
29.2 	(i) an application fee of $2,500;
29.3 	(ii) an initial license fee of $2,500; and
29.4 	(iii) a renewal license fee of $5,000;
29.5 	(6) for a cannabis wholesaler:
29.6 	(i) an application fee of $5,000;
29.7 	(ii) an initial license fee of $5,000; and
29.8 	(iii) a renewal license fee of $10,000;
29.9 	(7) for a cannabis transporter:
29.10 	(i) an application fee of $250;
29.11 	(ii) an initial license fee of $500; and
29.12 	(iii) a renewal license fee of $1,000;
29.13 	(8) for a cannabis testing facility:
29.14 	(i) an application fee of $5,000;
29.15 	(ii) an initial license fee of $5,000; and
29.16 	(iii) a renewal license fee of $10,000;
29.17 	(9) for a cannabis delivery service:
29.18 	(i) an application fee of $250;
29.19 	(ii) an initial license fee of $500; and
29.20 	(iii) a renewal license fee of $1,000;
29.21 	(10) for a cannabis event organizer:
29.22 	(i) an application fee of $750; and
29.23 	(ii) an initial license fee of $750;
29.24 	(11) for a lower-potency hemp edible manufacturer:
29.25 	(i) an application fee of $250;
29.26 	(ii) an initial license fee of $1,000; and
29.27 	(iii) a renewal license fee of $1,000;
30.1 	(12) for a lower-potency hemp edible wholesaler:
30.2 	(i) an application fee of $250;
30.3 	(ii) an initial license fee of $10,000; and
30.4 	(iii) a renewal license fee of $10,000;
30.5 	(12) (13) for a lower-potency hemp edible retailer:
30.6 	(i) an application fee of $250 or, if the lower-potency hemp retailer operates more than 
30.7 	one retail location, $250 per retail location;
30.8 	(ii) an initial license fee of $250 or, if the lower-potency hemp retailer operates more 
30.9 	than one retail location, $250 per retail location; and
30.10 	(iii) a renewal license fee of $250 or, if the lower-potency hemp retailer operates more 
30.11 	than one retail location, $250 per retail location; and
30.12 	(13) (14) for a medical cannabis combination business:
30.13 	(i) an application fee of $10,000;
30.14 	(ii) an initial license fee of $20,000; and
30.15 	(iii) a renewal license fee of $70,000.

30.16 	Sec. 40. Minnesota Statutes 2024, section 342.12, is amended to read:
30.17 	342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
30.18 	(a) Licenses issued under this chapter that are available to all applicants pursuant to 
30.19 	section 342.14, subdivision 1b, paragraph (c), may be freely transferred subject to the prior 
30.20 	written approval of the office unless the license holder has not received a final site inspection 
30.21 	or the license holder is a social equity applicant.
30.22 	(b) Licenses issued as social equity licenses pursuant to either section 342.14, subdivision 
30.23 	1b, paragraph (b), or section 342.175, paragraph (b), may only be transferred to another 
30.24 	social equity applicant for three years after the date on which the office issues the license. 
30.25 	Three years after the date of issuance, a license holder may transfer a license to any entity. 
30.26 	Transfer of a license that was issued as a social equity license must be reviewed by the 
30.27 	Division of Social Equity and is subject to the prior written approval of the office.
30.28 	(c) Preliminary license preapproval approval issued pursuant to section 342.125342.14, 
30.29 	subdivision 5, may not be transferred.
30.30 	(d) A new license must be obtained when:
31.1 	(1) the form of the licensee's legal business structure converts or changes to a different 
31.2 	type of legal business structure; or
31.3 	(2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency, 
31.4 	or receivership proceedings; merges with another legal organization; or assigns all or 
31.5 	substantially all of its assets for the benefit of creditors.
31.6 	(e) Licenses must be renewed annually.
31.7 	(f) License holders may petition the office to adjust the tier of a license issued within a 
31.8 	license category if the license holder meets all applicable requirements.
31.9 	(g) The office by rule may permit the relocation of a licensed cannabis business; permit 
31.10 	the relocation of an approved operational location, including a cultivation, manufacturing, 
31.11 	processing, or retail location; adopt requirements for the submission of a license relocation 
31.12 	application; establish standards for the approval of a relocation application; and charge a 
31.13 	fee not to exceed $250 for reviewing and processing applications. Relocation of a licensed 
31.14 	premises pursuant to this paragraph does not extend or otherwise modify the license term 
31.15 	of the license subject to relocation.

31.16 	Sec. 41. Minnesota Statutes 2024, section 342.13, is amended to read:
31.17 	342.13 LOCAL CONTROL.
31.18 	(a) A local unit of government may not prohibit the possession, transportation, or use 
31.19 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
31.20 	consumer products authorized under this chapter.
31.21 	(b) Except as provided in section 342.22, a local unit of government may not prohibit 
31.22 	the establishment or operation of a cannabis business or hemp business licensed under this 
31.23 	chapter.
31.24 	(c) A local unit of government may adopt reasonable restrictions on the time, place, and 
31.25 	manner of the operation of a cannabis business provided that such restrictions do not prohibit 
31.26 	the establishment or operation of cannabis businesses. A local unit of government may 
31.27 	prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a 
31.28 	day care, residential treatment facility, or an attraction within a public park that is regularly 
31.29 	used by minors, including a playground or athletic field.
31.30 	(d) The office shall work with local units of government to:
31.31 	(1) develop model ordinances for reasonable restrictions on the time, place, and manner 
31.32 	of the operation of a cannabis business;
32.1 	(2) develop standardized forms and procedures for the issuance of a retail registration 
32.2 	pursuant to section 342.22; and
32.3 	(3) develop model policies and procedures for the performance of compliance checks 
32.4 	required under section 342.22.
32.5 	(e) If a local unit of government is conducting studies or has authorized a study to be 
32.6 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
32.7 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
32.8 	a cannabis business, the governing body of the local unit of government may adopt an 
32.9 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
32.10 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
32.11 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
32.12 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
32.13 	or a portion thereof until January 1, 2025.
32.14 	(f) Within 30 days of receiving a copy of an application from the office, a local unit of 
32.15 	government shall certify on a form provided by the office whether a proposed cannabis 
32.16 	business complies with local zoning ordinances and, if applicable, whether the proposed 
32.17 	business complies with the state fire code and building code. The office may not issue a 
32.18 	license if the local unit of government informs the office that the cannabis business does 
32.19 	not meet local zoning and land use laws. If the local unit of government does not provide 
32.20 	the certification to the office within 30 days of receiving a copy of an application from the 
32.21 	office, the office may issue a license.
32.22 	(g) The office by rule shall establish an expedited complaint process to receive, review, 
32.23 	and respond to complaints made by a local unit of government about a cannabis business. 
32.24 	At a minimum, the expedited complaint process shall require the office to provide an initial 
32.25 	response to the complaint within seven days and perform any necessary inspections within 
32.26 	30 days. Nothing in this paragraph prohibits a local unit of government from enforcing a 
32.27 	local ordinance. If a local unit of government notifies the office that a cannabis business 
32.28 	other than a cannabis retailer, cannabis microbusiness or, cannabis mezzobusiness or 
32.29 	lower-potency hemp edible retailer with a retail operations endorsement, lower-potency 
32.30 	hemp edible retailer, or medical cannabis combination business operating a retail location 
32.31 	poses an immediate threat to the health or safety of the public, the office must respond 
32.32 	within one business day and may take any action described in section 342.19 or 342.21.
32.33 	(h) A local government unit that issues a cannabis retailer registration under section 
32.34 	342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis 
33.1 	mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with 
33.2 	a retail operations endorsement to no fewer than one registration for every 12,500 residents.
33.3 	(i) If a county has one active registration for every 12,500 residents, a city or town within 
33.4 	the county is not obligated to register a cannabis business.
33.5 	(j) Nothing in this section shall prohibit a local government unit from allowing licensed 
33.6 	cannabis retailers in excess of the minimums set in paragraph (h).
33.7 	(k) Notwithstanding the foregoing provisions, the state shall not issue a license to any 
33.8 	cannabis business to operate in Indian country, as defined in United States Code, title 18, 
33.9 	section 1151, of a Minnesota Tribal government without the consent of the Tribal 
33.10 	government.

33.11 	Sec. 42. Minnesota Statutes 2024, section 342.14, subdivision 1, is amended to read:
33.12 		Subdivision 1.Application; contents. (a) The office shall establish procedures for the 
33.13 	processing of cannabis licenses issued under this chapter. At a minimum, any application 
33.14 	to obtain or renew a cannabis license shall include the following information, if applicable:
33.15 	(1) the name, address, and date of birth of the applicant;
33.16 	(2) the disclosure of ownership and control required under paragraph (b);
33.17 	(3) the disclosure of whether the applicant or, if the applicant is a business, any officer, 
33.18 	director, manager, and general partner of the business has ever filed for bankruptcy;
33.19 	(4) the address and legal property description of the business, if applicable, except an 
33.20 	applicant is not required to secure a physical premises for the business at the time of 
33.21 	application;
33.22 	(5) a general description of the location or locations that the applicant plans to operate, 
33.23 	including the planned square feet of space for cultivation, wholesaling, and retailing, as 
33.24 	applicable;
33.25 	(6) a copy of the security plan, including security monitoring, security equipment, and 
33.26 	facility maps if applicable, except an applicant is not required to secure a physical premises 
33.27 	for the business at the time of application;
33.28 	(7) proof of trade name registration;
33.29 	(8) a copy of the applicant's business plan showing the expected size of the business; 
33.30 	anticipated growth; the methods of record keeping; the knowledge and experience of the 
34.1 	applicant and any officer, director, manager, and general partner of the business; the 
34.2 	environmental plan; and other relevant financial and operational components;
34.3 	(9) standard operating procedures for:
34.4 	(i) quality assurance;
34.5 	(ii) inventory control, storage, and diversion prevention; and
34.6 	(iii) accounting and tax compliance;
34.7 	(10) an attestation signed by a bona fide labor organization stating that the applicant has 
34.8 	entered into a labor peace agreement;
34.9 	(11) a description of any training and education that the applicant will provide to 
34.10 	employees of the business;
34.11 	(12) a disclosure of any violation of a license agreement or a federal, state, or local law 
34.12 	or regulation committed by the applicant or any true party of interest in the applicant's 
34.13 	business that is relevant to business and working conditions;
34.14 	(13) certification that the applicant will comply with the requirements of this chapter;
34.15 	(14) identification of one or more controlling persons or managerial employees as agents 
34.16 	who shall be responsible for dealing with the office on all matters;
34.17 	(15) a statement that the applicant agrees to respond to the office's supplemental requests 
34.18 	for information; and
34.19 	(16) a release of information for the applicant and every true party of interest in the 
34.20 	applicant's business license for the office to perform the background checks required under 
34.21 	section 342.15.;
34.22 	(17) proof that the applicant is a social equity applicant; and
34.23 	(18) an attestation that the applicant's business policies governing business operations 
34.24 	comply with this chapter.
34.25 	(b) An applicant must file and update as necessary a disclosure of ownership and control 
34.26 	identifying any true party of interest as defined in section 342.185, subdivision 1, paragraph 
34.27 	(g). The office shall establish the contents of the disclosure. Except as provided in paragraph 
34.28 	(f) (e), the disclosure shall, at a minimum, include the following:
34.29 	(1) the management structure, ownership, and control of the applicant or license holder, 
34.30 	including the name of each cooperative member, officer, director, manager, general partner, 
34.31 	or business entity; the office or position held by each person; each person's percentage 
35.1 	ownership interest, if any; and, if the business has a parent company, the name of each 
35.2 	owner, board member, and officer of the parent company and the owner's, board member's, 
35.3 	or officer's percentage ownership interest in the parent company and the cannabis business;
35.4 	(2) a statement from the applicant and, if the applicant is a business, from every officer, 
35.5 	director, manager, and general partner of the business, indicating whether that person has 
35.6 	previously held, or currently holds, an ownership interest in a cannabis business in Minnesota, 
35.7 	any other state or territory of the United States, or any other country;
35.8 	(3) if the applicant is a corporation, copies of the applicant's articles of incorporation 
35.9 	and bylaws and any amendments to the applicant's articles of incorporation or bylaws;
35.10 	(4) copies of any partnership agreement, operating agreement, or shareholder agreement;
35.11 	(5) copies of any promissory notes, security instruments, or other similar agreements;
35.12 	(6) an explanation detailing the funding sources used to finance the business;
35.13 	(7) a list of operating and investment accounts for the business, including any applicable 
35.14 	financial institution and account number; and
35.15 	(8) a list of each outstanding loan and financial obligation obtained for use in the business, 
35.16 	including the loan amount, loan terms, and name and address of the creditor.
35.17 	(c) An application may include:
35.18 	(1) proof that the applicant is a social equity applicant;
35.19 	(2) a description of the training and education that will be provided to any employee; 
35.20 	or
35.21 	(3) a copy of business policies governing operations to ensure compliance with this 
35.22 	chapter.
35.23 	(d) (c) Commitments made by an applicant in its application, including but not limited 
35.24 	to the maintenance of a labor peace agreement, shall be an ongoing material condition of 
35.25 	maintaining and renewing the license.
35.26 	(d) A labor peace agreement entered into on or after August 15, 2025, must address the 
35.27 	duration of the election.
35.28 	(e) An application on behalf of a corporation or association shall be signed by at least 
35.29 	two officers or managing agents of that entity.
36.1 	(f) (e) The office may establish exceptions to the disclosures required under paragraph 
36.2 	(b) for members of a cooperative who hold less than a five percent ownership interest in 
36.3 	the cooperative.

36.4 	Sec. 43. Minnesota Statutes 2024, section 342.14, subdivision 3, is amended to read:
36.5 		Subd. 3.Review. (a) After an applicant submits an application that contains all required 
36.6 	information and pays the applicable licensing application fee, the office must review the 
36.7 	application.
36.8 	(b) The office may deny an application if:
36.9 	(1) the application is incomplete;
36.10 	(2) the application contains a materially false statement about the applicant or omits 
36.11 	information required under subdivision 1;
36.12 	(3) the applicant does not meet the qualifications under section 342.16;
36.13 	(4) the applicant is prohibited from holding the license under section 342.18, subdivision 
36.14 	2;
36.15 	(5) the application does not meet the minimum requirements under section 342.18, 
36.16 	subdivision 3;
36.17 	(6) the applicant fails to pay the applicable application fee;
36.18 	(7) the application was not submitted by the application deadline;
36.19 	(8) the applicant submitted more than one application for a license type; or
36.20 	(9) the office determines that the applicant would be prohibited from holding a license 
36.21 	for any other reason.
36.22 	(c) If the office denies an application, the office must notify the applicant of the denial 
36.23 	and the basis for the denial.
36.24 	(d) The office may request additional information from any applicant if the office 
36.25 	determines that the information is necessary to review or process the application. If the 
36.26 	applicant does not provide the additional requested information within 14 calendar days of 
36.27 	the office's request for information, the office may deny the application.
36.28 	(e) An applicant whose application is not denied under this subdivision is a qualified 
36.29 	applicant.

37.1 	Sec. 44. Minnesota Statutes 2024, section 342.14, subdivision 6, is amended to read:
37.2 		Subd. 6.Completed application; final authorization; issuance of license. (a) Within 
37.3 	18 months of receiving notice of preliminary license approval, an applicant must provide:
37.4 	(1) the address and legal property description of the location where the business will 
37.5 	operate;
37.6 	(2) the name of the local unit of government where the business will be located; and
37.7 	(3) if applicable, an updated description of the location where the business will operate, 
37.8 	an updated security plan, and any other additional information required by the office.
37.9 	(b) Upon receipt of the information required under paragraph (a) from an applicant that 
37.10 	has received preliminary license approval, the office must:
37.11 	(1) forward a copy of the application to the local unit of government in which the business 
37.12 	operates or intends to operate with a form for certification as to whether a proposed cannabis 
37.13 	business complies with local zoning ordinances and, if applicable, whether the proposed 
37.14 	business complies with the state fire code and building code;
37.15 	(2) schedule a site inspection; and
37.16 	(3) require the applicant to pay the applicable license fee.
37.17 	(c) The office may deny final authorization if:
37.18 	(1) an applicant fails to submit any required information;
37.19 	(2) the applicant submits a materially false statement about the applicant or fails to 
37.20 	provide any required information;
37.21 	(3) the office confirms that the cannabis business for which the office granted a 
37.22 	preliminary license preapproval approval does not meet local zoning and land use laws;
37.23 	(4) the applicant fails to pay the applicable license fee; or
37.24 	(5) the office determines that the applicant is disqualified from holding the license or 
37.25 	would operate in violation of the provisions of this chapter.
37.26 	(d) Within 90 days of receiving the information required under paragraph (a) and the 
37.27 	results of any required background check, the office shall grant final authorization and issue 
37.28 	the appropriate license or send the applicant a notice of rejection setting forth specific 
37.29 	reasons that the office did not approve the application.

38.1 	Sec. 45. Minnesota Statutes 2024, section 342.151, subdivision 2, is amended to read:
38.2 		Subd. 2.Criminal history check. A license holder cannabis business may employ or 
38.3 	contract with as many unlicensed individuals as may be necessary, provided that the license 
38.4 	holder cannabis business is at all times accountable for the good conduct of every individual 
38.5 	employed by or contracted with the license holder cannabis business. Before hiring an 
38.6 	individual as a cannabis worker, the license holder cannabis business must submit to the 
38.7 	Bureau of Criminal Apprehension the individual's full set of fingerprints and written consent 
38.8 	for the bureau to conduct a state and national criminal history check. The bureau may 
38.9 	exchange an individual's fingerprints with the Federal Bureau of Investigation. The Bureau 
38.10 	of Criminal Apprehension must determine whether the individual is qualified to be employed 
38.11 	as a cannabis worker and must notify the license holdercannabis business of the bureau's 
38.12 	determination. The license holder cannabis business must not employ an individual who is 
38.13 	disqualified from being employed as a cannabis worker.

38.14 	Sec. 46. Minnesota Statutes 2024, section 342.151, subdivision 3, is amended to read:
38.15 		Subd. 3.Disqualification. (a) A license holder cannabis business must not employ an 
38.16 	individual as a cannabis worker if the individual has been convicted of any of the following 
38.17 	crimes that would constitute a felony:
38.18 	(1) human trafficking;
38.19 	(2) noncannabis controlled substance crimes in the first or second degree;
38.20 	(3) labor trafficking;
38.21 	(4) fraud;
38.22 	(5) embezzlement;
38.23 	(6) extortion;
38.24 	(7) money laundering; or
38.25 	(8) insider trading;
38.26 	if committed in this state or any other jurisdiction for which a full pardon or similar relief 
38.27 	has not been granted.
38.28 	(b) A license holder cannabis business must not employ an individual as a cannabis 
38.29 	worker if the individual made any false statement in an application for employment.

39.1 	Sec. 47. Minnesota Statutes 2024, section 342.16, is amended to read:
39.2 	342.16 CANNABIS BUSINESSES; GENERAL OWNERSHIP 
39.3 	DISQUALIFICATIONS AND REQUIREMENTS.
39.4 	(a) A license holder or applicant must meet each of the following requirements, if 
39.5 	applicable, to hold or receive a cannabis license issued under this chapter:
39.6 	(1) be at least 21 years of age;
39.7 	(2) have completed an application for licensure or application for renewal;
39.8 	(3) have paid the applicable application fee and license fee;
39.9 	(4) if the applicant or license holder is a business entity, be incorporated in the state or 
39.10 	otherwise formed or organized under the laws of the state;
39.11 	(5) not be employed by the office or any state agency with regulatory authority under 
39.12 	this chapter or the rules adopted pursuant to this chapter;
39.13 	(6) not be a licensed peace officer, as defined in section 626.84, subdivision 1, paragraph 
39.14 	(c);
39.15 	(7) never have had a license previously issued under this chapter revoked, and never 
39.16 	have had a cannabis license, a registration, an agreement, or another authorization to operate 
39.17 	a cannabis business issued under the laws of another state revoked;
39.18 	(8) have filed any previously required tax returns for a cannabis business;
39.19 	(9) have paid and remitted any business taxes, gross receipts taxes, interest, or penalties 
39.20 	due relating to the operation of a cannabis business;
39.21 	(10) have fully and truthfully complied with all information requests of the office relating 
39.22 	to license application and renewal;
39.23 	(11) not be disqualified under section 342.15;
39.24 	(12) not employ an individual who is disqualified from working for a cannabis business 
39.25 	under this chapter;
39.26 	(13) meet the ownership and operational requirements for the type of license and, if 
39.27 	applicable, endorsement sought or held; and
39.28 	(14) not have had any confirmed willful labor violation with the Department of Labor, 
39.29 	National Labor Relations Board, or the Occupational Safety and Health Administration 
39.30 	within the last five years, as determined by the office.
40.1 	(b) A health care practitioner who certifies qualifying medical conditions for patients is 
40.2 	prohibited from:
40.3 	(1) holding a direct or indirect economic interest in a cannabis business;
40.4 	(2) serving as a cooperative member, director, manager, general partner, or employee 
40.5 	of a cannabis business; or
40.6 	(3) advertising with a cannabis business in any way.
40.7 	(c) If the license holder or applicant is a business entity, every officer, director, manager, 
40.8 	and general partner of the business entity must meet each of the requirements of this section.
40.9 	(d) The ownership disqualifications and requirements under this section do not apply to 
40.10 	a hemp business license holder or applicant.

40.11 	Sec. 48. Minnesota Statutes 2024, section 342.17, is amended to read:
40.12 	342.17 SOCIAL EQUITY APPLICANTS.
40.13 	(a) An applicant qualifies as a social equity applicant if the applicant:
40.14 	(1) was found delinquent for, received a stay of adjudication for, or was convicted of 
40.15 	an offense involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
40.16 	(2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense 
40.17 	involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
40.18 	(3) was a dependent of an individual who was convicted of an offense involving the 
40.19 	possession or sale of cannabis or marijuana prior to May 1, 2023;
40.20 	(4) is a military veteran, including a service-disabled veteran, current or former member 
40.21 	of the national guard;
40.22 	(5) is a military veteran or current or former member of the national guard who lost 
40.23 	honorable status due to an offense involving the possession or sale of cannabis or marijuana;
40.24 	(6) has been a resident for the last five years of one or more subareas, such as census 
40.25 	tracts or neighborhoods:
40.26 	(i) that experienced a disproportionately large amount of cannabis enforcement as 
40.27 	determined by the study conducted by the office pursuant to section 342.04, paragraph (b), 
40.28 	or another report based on federal or state data on arrests or convictions;
40.29 	(ii) where the poverty rate was 20 percent or more;
41.1 	(iii) where the median family income did not exceed 80 percent of the statewide median 
41.2 	family income or, if in a metropolitan area, did not exceed the greater of 80 percent of the 
41.3 	statewide median family income or 80 percent of the median family income for that 
41.4 	metropolitan area;
41.5 	(iv) where at least 20 percent of the households receive assistance through the 
41.6 	Supplemental Nutrition Assistance Program; or
41.7 	(v) where the population has a high level of vulnerability according to the Centers for 
41.8 	Disease Control and Prevention and Agency for Toxic Substances and Disease Registry 
41.9 	(CDC/ATSDR) Social Vulnerability Index; or
41.10 	(7) has participated in the business operation of a farm for at least three years and 
41.11 	currently provides the majority of the day-to-day physical labor and management of a farm 
41.12 	that had gross farm sales of at least $5,000 but not more than $100,000 in the previous year.
41.13 	(b) The qualifications described in paragraph (a) apply to each individual applicant or, 
41.14 	in the case of a business entity, apply to at least 65 percent of the controlling ownership of 
41.15 	the business entity.

41.16 	Sec. 49. Minnesota Statutes 2024, section 342.18, subdivision 2, is amended to read:
41.17 		Subd. 2.Vertical integration prohibited; exceptions. (a) Except as otherwise provided 
41.18 	in this subdivision, the office shall not issue licenses to a single applicant that would result 
41.19 	in the applicant being vertically integrated in violation of the provisions of this chapter.
41.20 	(b) Nothing in this section prohibits or limits the issuance of microbusiness licenses, 
41.21 	mezzobusiness licenses, or medical cannabis combination business licenses, or the issuance 
41.22 	of both lower-potency hemp edible manufacturer, lower-potency hemp edible wholesaler,
41.23 	and lower-potency hemp edible retailer licenses to the same person or entity.

41.24 	Sec. 50. Minnesota Statutes 2024, section 342.22, subdivision 3, is amended to read:
41.25 		Subd. 3.Issuance of registration. (a) A local unit of government shall issue a retail 
41.26 	registration to a cannabis microbusiness with a retail operations endorsement, cannabis 
41.27 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
41.28 	combination business operating a retail location, or lower-potency hemp edible retailer that:
41.29 	(1) has a valid license or preliminary license preapproval approval issued by the office;
41.30 	(2) has paid the registration fee or renewal fee pursuant to subdivision 2;
42.1 	(3) is found to be in compliance with the requirements of this chapter at any preliminary 
42.2 	compliance check that the local unit of government performs; and
42.3 	(4) if applicable, is current on all property taxes and assessments at the location where 
42.4 	the retail establishment is located.
42.5 	(b) Before issuing a retail registration, the local unit of government may conduct a 
42.6 	preliminary compliance check to ensure that the cannabis business or hemp business is in 
42.7 	compliance with any applicable local ordinance established pursuant to section 342.13.
42.8 	(c) A local unit of government shall renew the retail registration of a cannabis business 
42.9 	or hemp business when the office renews the license of the cannabis business or hemp 
42.10 	business.
42.11 	(d) A retail registration issued under this section may not be transferred.

42.12 	Sec. 51. Minnesota Statutes 2024, section 342.22, is amended by adding a subdivision to 
42.13 	read:
42.14 		Subd. 6.Exception; exclusive delivery services. The requirements of this section do 
42.15 	not apply to a lower-potency hemp edible retailer with a delivery endorsement if the 
42.16 	lower-potency hemp edible retailer does not operate a retail location.

42.17 	Sec. 52. Minnesota Statutes 2024, section 342.28, subdivision 1, is amended to read:
42.18 		Subdivision 1.Authorized actions. A cannabis microbusiness license, consistent with 
42.19 	the specific license endorsement or endorsements, entitles the license holder to perform any 
42.20 	or all of the following within the limits established by this section:
42.21 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
42.22 	cannabis flower from a mature plant;
42.23 	(2) make cannabis concentrate;
42.24 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
42.25 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
42.26 	(4) manufacture artificially derived cannabinoids;
42.27 	(5) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
42.28 	hemp-derived consumer products for public consumption;
42.29 	(6) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis 
42.30 	products, lower-potency hemp edibles, and hemp-derived consumer products from another 
43.1 	cannabis microbusiness, a cannabis mezzobusiness, a cannabis cultivator, a cannabis 
43.2 	manufacturer, or a cannabis wholesaler, a medical cannabis combination business, a 
43.3 	lower-potency hemp edible manufacturer, or a lower-potency hemp edible wholesaler;
43.4 	(7) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
43.5 	under chapter 18K;
43.6 	(8) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
43.7 	18K;
43.8 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
43.9 	from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, 
43.10 	or a cannabis wholesaler for use in manufacturing adult-use cannabis products, lower-potency 
43.11 	hemp edibles, or hemp-derived consumer products;
43.12 	(10) package and label adult-use cannabis flower, adult-use cannabis products, 
43.13 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
43.14 	(11) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
43.15 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
43.16 	other products authorized by law to other cannabis businesses and to customers;
43.17 	(12) operate an establishment that permits on-site consumption of edible cannabis 
43.18 	products and lower-potency hemp edibles; and
43.19 	(13) perform other actions approved by the office.

43.20 	Sec. 53. Minnesota Statutes 2024, section 342.28, subdivision 8, is amended to read:
43.21 		Subd. 8.Production of customer consumer products endorsement. A cannabis 
43.22 	microbusiness that manufactures edible cannabis products, lower-potency hemp products, 
43.23 	or hemp-derived consumer products must comply with the requirements in section 342.26, 
43.24 	subdivisions 2 and 4.

43.25 	Sec. 54. Minnesota Statutes 2024, section 342.29, subdivision 1, is amended to read:
43.26 		Subdivision 1.Authorized actions. A cannabis mezzobusiness license, consistent with 
43.27 	the specific license endorsement or endorsements, entitles the license holder to perform any 
43.28 	or all of the following within the limits established by this section:
43.29 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
43.30 	cannabis flower from a mature plant for use as adult-use cannabis flower or for use in 
43.31 	adult-use cannabis products;
44.1 	(2) grow cannabis plants from seed or immature plant to mature plant and harvest 
44.2 	cannabis flower from a mature plant for use as medical cannabis flower or for use in medical 
44.3 	cannabinoid products;
44.4 	(3) make cannabis concentrate;
44.5 	(4) make hemp concentrate, including hemp concentrate with a delta-9 
44.6 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
44.7 	(5) manufacture artificially derived cannabinoids;
44.8 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
44.9 	hemp-derived consumer products for public consumption;
44.10 	(7) process medical cannabinoid products;
44.11 	(8) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis 
44.12 	products, lower-potency hemp edibles, and hemp-derived consumer products from a cannabis 
44.13 	microbusiness, another cannabis mezzobusiness, a cannabis cultivator, a cannabis 
44.14 	manufacturer, or a cannabis wholesaler, a medical cannabis combination business, a 
44.15 	lower-potency hemp edible manufacturer, or a lower-potency hemp edible wholesaler;
44.16 	(9) purchase cannabis concentrate, hemp concentrate, and synthetically artificially derived 
44.17 	cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis 
44.18 	manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products, 
44.19 	lower-potency hemp edibles, or hemp-derived consumer products;
44.20 	(10) purchase hemp plant parts and propagules from a licensed hemp grower licensed 
44.21 	under chapter 18K;
44.22 	(11) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
44.23 	18K;
44.24 	(12) package and label adult-use cannabis flower, adult-use cannabis products, 
44.25 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
44.26 	(13) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
44.27 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
44.28 	other products authorized by law to other cannabis businesses and to customers; and
44.29 	(14) perform other actions approved by the office.

45.1 	Sec. 55. Minnesota Statutes 2024, section 342.29, subdivision 7, is amended to read:
45.2 		Subd. 7.Production of customer consumer products endorsement. A cannabis 
45.3 	mezzobusiness that manufactures edible cannabis products, lower-potency hemp products, 
45.4 	or hemp-derived consumer products must comply with the requirements in section 342.26, 
45.5 	subdivisions 2 and 4.

45.6 	Sec. 56. Minnesota Statutes 2024, section 342.30, subdivision 1, is amended to read:
45.7 		Subdivision 1.Authorized actions. A cannabis cultivator license entitles the license 
45.8 	holder to:
45.9 	(1) grow cannabis plants within the approved amount of space from seed or immature 
45.10 	plant to mature plant,;
45.11 	(2) harvest cannabis flower from a mature plant,;
45.12 	(3) package and label immature cannabis plants and seedlings and cannabis flower for 
45.13 	sale to other cannabis businesses,;
45.14 	(4) sell immature cannabis plants and seedlings and cannabis flower to other cannabis 
45.15 	businesses;
45.16 	(5) transport cannabis flower to a cannabis manufacturer located on the same premises,;
45.17 	and
45.18 	(6) perform other actions approved by the office.

45.19 	Sec. 57. Minnesota Statutes 2024, section 342.32, subdivision 1, is amended to read:
45.20 		Subdivision 1.Authorized actions. A cannabis retailer license entitles the license holder 
45.21 	to:
45.22 	(1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products, 
45.23 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
45.24 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
45.25 	and cannabis wholesalers, and medical cannabis combination businesses;
45.26 	(2) purchase lower-potency hemp edibles from a licensed lower-potency hemp edible 
45.27 	manufacturer or lower-potency hemp edible wholesaler;
45.28 	(3) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
45.29 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
45.30 	other products authorized by law to customers; and
46.1 	(4) perform other actions approved by the office.

46.2 	Sec. 58. Minnesota Statutes 2024, section 342.32, subdivision 4, is amended to read:
46.3 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
46.4 	cannabis retailer license may also hold a cannabis delivery service license and a cannabis 
46.5 	event organizer license.
46.6 	(b) Except as provided in paragraph (a) and subdivision 5, no person, cooperative, or 
46.7 	business holding a cannabis retailer license may own or operate any other cannabis business 
46.8 	or hemp business.
46.9 	(c) No person, cooperative, or business may hold a license to own or operate more than 
46.10 	one cannabis retail business in one city and three retail businesses in one county.
46.11 	(d) The office by rule may limit the number of cannabis retailer licenses a person, 
46.12 	cooperative, or business may hold.
46.13 	(e) For purposes of this subdivision, a restriction on the number or type of license a 
46.14 	business may hold applies to every cooperative member or every director, manager, and 
46.15 	general partner of a cannabis business.

46.16 	Sec. 59. Minnesota Statutes 2024, section 342.32, subdivision 5, is amended to read:
46.17 		Subd. 5.Municipal or county cannabis store. A city or county may establish, own, 
46.18 	and operate a municipal cannabis store subject to the restrictions in this chapter.
46.19 	Notwithstanding any law to the contrary, a city or county that establishes, owns, or operates 
46.20 	a municipal cannabis store may also hold a lower-potency hemp edible retailer license.

46.21 	Sec. 60. Minnesota Statutes 2024, section 342.33, subdivision 1, is amended to read:
46.22 		Subdivision 1.Authorized actions. A cannabis wholesaler license entitles the license 
46.23 	holder to:
46.24 	(1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products, 
46.25 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
46.26 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
46.27 	medical cannabis combination businesses, and cannabis microbusinesses lower-potency 
46.28 	hemp edible manufacturers;
46.29 	(2) purchase hemp plant parts and propagules from industrial hemp growers licensed 
46.30 	under chapter 18K;
47.1 	(3) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
47.2 	18K;
47.3 	(4) sell immature cannabis plants and seedlings, cannabis flower, cannabis products, 
47.4 	lower-potency hemp edibles, and hemp-derived consumer products to cannabis 
47.5 	microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, and cannabis retailers;
47.6 	(5) sell lower-potency hemp edibles to lower-potency hemp edible retailers;
47.7 	(6) import hemp-derived consumer products and lower-potency hemp edibles that contain 
47.8 	hemp concentrate or artificially derived cannabinoids that are derived from hemp plants or 
47.9 	hemp plant parts; and
47.10 	(7) perform other actions approved by the office.

47.11 	Sec. 61. Minnesota Statutes 2024, section 342.34, subdivision 5, is amended to read:
47.12 		Subd. 5.Importation of hemp-derived products. (a) A cannabis wholesaler that imports 
47.13 	lower-potency hemp edibles or hemp-derived consumer products, other than hemp-derived 
47.14 	topical products, that are manufactured outside the boundaries of the state of Minnesota 
47.15 	with the intent to sell the products to a cannabis microbusiness, cannabis mezzobusiness, 
47.16 	cannabis retailer, lower-potency hemp edible wholesaler, or lower-potency hemp edible 
47.17 	retailer must obtain a hemp-derived product importer endorsement from the office.
47.18 	(b) A cannabis wholesaler with a hemp-derived product importer endorsement may sell 
47.19 	products manufactured outside the boundaries of the state of Minnesota if:
47.20 	(1) the manufacturer is licensed in another jurisdiction and subject to regulations designed 
47.21 	to protect the health and safety of consumers that the office determines are substantially 
47.22 	similar to the regulations in this state; or
47.23 	(2) the cannabis wholesaler establishes, to the satisfaction of the office, that the 
47.24 	manufacturer engages in practices that are substantially similar to the practices required for 
47.25 	licensure of manufacturers in this state.
47.26 	(c) The cannabis wholesaler must enter all relevant information regarding an imported 
47.27 	hemp-derived consumer product into the statewide monitoring system before the product 
47.28 	may be distributed. Relevant information includes information regarding the cultivation, 
47.29 	processing, and testing of the industrial hemp used in the manufacture of the product and 
47.30 	information regarding the testing of the hemp-derived consumer product. If information 
47.31 	regarding the industrial hemp or hemp-derived consumer product was submitted to a 
47.32 	statewide monitoring system used in another state, the office may require submission of 
48.1 	any information provided to that statewide monitoring system and shall assist in the transfer 
48.2 	of data from another state as needed and in compliance with any data classification 
48.3 	established by either state.
48.4 	(d) The office may suspend, revoke, or cancel the endorsement of a distributor who is 
48.5 	prohibited from distributing products containing cannabinoids in any other jurisdiction, 
48.6 	convicted of an offense involving the distribution of products containing cannabinoids in 
48.7 	any other jurisdiction, or found liable for distributing any product that injured customers in 
48.8 	any other jurisdiction. A cannabis wholesaler shall disclose all relevant information related 
48.9 	to actions in another jurisdiction. Failure to disclose relevant information may result in 
48.10 	disciplinary action by the office, including the suspension, revocation, or cancellation of 
48.11 	an endorsement or license.
48.12 	(e) Notwithstanding any law to the contrary, it shall not be a defense in any civil or 
48.13 	criminal action that a licensed wholesaler relied on information on a product label or 
48.14 	otherwise provided by a manufacturer who is not licensed in this state.

48.15 	Sec. 62. Minnesota Statutes 2024, section 342.36, subdivision 6, is amended to read:
48.16 		Subd. 6.Multiple employees; secured vehicles; delivery routes. All cannabis transporter 
48.17 	vehicles transporting immature cannabis plants and seedlings, cannabis flower, cannabis 
48.18 	products, artificially derived cannabinoids, hemp plant parts, hemp concentrate, 
48.19 	lower-potency hemp edibles, or hemp-derived consumer products must be staffed with a 
48.20 	minimum of two employees (1) secured by turning off the ignition, locking all doors and 
48.21 	storage compartments, and removing the operating keys or device, or (2) attended by a 
48.22 	cannabis transporter employee at all times. If there are multiple team members staffing an 
48.23 	unsecured transport vehicle, at least one delivery team member shall remain with the motor 
48.24 	vehicle at all times that the motor vehicle contains immature cannabis plants and seedlings, 
48.25 	cannabis flower, cannabis products, artificially derived cannabinoids, hemp plant parts, 
48.26 	hemp concentrate, lower-potency hemp edibles, or hemp-derived consumer products. A 
48.27 	cannabis transporter must not be required to randomize delivery times and routes or staff 
48.28 	cannabis transport vehicles with multiple employees.

48.29 	Sec. 63. Minnesota Statutes 2024, section 342.37, subdivision 2, is amended to read:
48.30 		Subd. 2.Additional information required; exception. (a) In addition to the information 
48.31 	required to be submitted under section 342.14, subdivision 1, and rules adopted pursuant 
48.32 	to that section, a person, cooperative, or business seeking a cannabis testing facility license 
48.33 	must submit the following information in a form approved by the office:
49.1 	(1) an operating plan demonstrating the proposed layout of the facility, including a 
49.2 	diagram of ventilation and filtration systems and policies to avoid sales to unlicensed 
49.3 	businesses;
49.4 	(2) proof of accreditation by a laboratory accrediting organization approved by the office 
49.5 	that, at a minimum, requires a laboratory to operate formal management systems under the 
49.6 	International Organization for Standardization; and
49.7 	(3) evidence that the business will comply with the applicable operation requirements 
49.8 	for the license being sought.
49.9 	(b) An independent laboratory approved to test medical cannabis produced by a medical 
49.10 	cannabis manufacturer pursuant to section 152.25 and Minnesota Rules, part 4770.2000, 
49.11 	before May 1, 2025, is not required to submit an attestation signed by a bona fide labor 
49.12 	organization stating that the applicant has entered into a labor peace agreement at the time 
49.13 	of an initial application for a cannabis testing facility license. A laboratory that receives a 
49.14 	cannabis testing facility license under this exception must submit an attestation signed by 
49.15 	a bona fide labor organization stating that the applicant has entered into a labor peace 
49.16 	agreement at the time of the second renewal of the license.

49.17 	Sec. 64. Minnesota Statutes 2024, section 342.37, is amended by adding a subdivision to 
49.18 	read:
49.19 		Subd. 2a.Cannabis testing facility licenses. (a) Pending an applicant's accreditation 
49.20 	by a laboratory accrediting organization approved by the office, the office may issue or 
49.21 	renew a cannabis testing facility license for an applicant that is a person, cooperative, or 
49.22 	business if the applicant:
49.23 	(1) submits documentation to the office demonstrating that the applicant has a signed 
49.24 	contract with a laboratory accreditation organization approved by the office, has scheduled 
49.25 	an audit, and is making progress toward accreditation by a laboratory accrediting organization 
49.26 	approved by the office according to the standards of the most recent edition of ISO/IEC 
49.27 	17025: General Requirements for the Competence of Testing and Calibration Laboratories;
49.28 	(2) passes a final site inspection conducted by the office; and
49.29 	(3) meets all other licensing requirements according to chapter 342 and Minnesota Rules.
49.30 	(b) After receiving a license under this section, a license holder may operate a cannabis 
49.31 	testing facility up to one year with pending accreditation status.
50.1 	(c) If after one year a license holder continues to have pending accreditation status, the 
50.2 	license holder may apply for a onetime extension to continue operations for up to six months. 
50.3 	The office may grant an extension under this paragraph to a license holder if the license 
50.4 	holder:
50.5 	(1) passes a follow-up site inspection conducted by the office;
50.6 	(2) submits an initial audit report from a laboratory accrediting organization approved 
50.7 	by the office; and
50.8 	(3) submits any additional information requested by the office.
50.9 	(d) The office may revoke a cannabis testing facility license held by a license holder 
50.10 	with pending accreditation status if the office determines or has reason to believe that the 
50.11 	license holder:
50.12 	(1) is not making progress toward accreditation; or
50.13 	(2) has violated a cannabis testing requirement, an ownership requirement, or an 
50.14 	operational requirement in chapter 342 or Minnesota Rules.
50.15 	(e) The office must not issue or renew a cannabis testing facility license under this 
50.16 	subdivision for a license holder if the license holder's accreditation has been suspended or 
50.17 	revoked by a laboratory accrediting organization.

50.18 	Sec. 65. Minnesota Statutes 2024, section 342.37, is amended by adding a subdivision to 
50.19 	read:
50.20 		Subd. 2b.Loss of accreditation. (a) A license holder must report loss of accreditation 
50.21 	to the office within 24 hours of receiving notice of the loss of accreditation.
50.22 	(b) The office must immediately revoke a license holder's license upon receiving notice 
50.23 	that the license holder has lost accreditation.

50.24 	Sec. 66. Minnesota Statutes 2024, section 342.39, subdivision 3, is amended to read:
50.25 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
50.26 	cannabis event organizer license may not hold a cannabis testing facility license, a 
50.27 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
50.28 	license, or a lower-potency hemp edible retailer license.
50.29 	(b) The office by rule may limit the number of cannabis event licenses that a person or 
50.30 	business may hold.
51.1 	(c) For purposes of this subdivision, restrictions on the number or type of license that a 
51.2 	business may hold apply to every cooperative member or every director, manager, and 
51.3 	general partner of a cannabis business.

51.4 	Sec. 67. Minnesota Statutes 2024, section 342.40, subdivision 7, is amended to read:
51.5 		Subd. 7.Cannabis event sales. (a) Cannabis microbusinesses with a retail endorsement, 
51.6 	cannabis mezzobusinesses with a retail endorsement, cannabis retailers, medical cannabis 
51.7 	combination businesses operating a retail location, and lower-potency hemp edible retailers, 
51.8 	including the cannabis event organizer, may be authorized to sell cannabis plants, adult-use 
51.9 	cannabis flower, adult-use cannabis products, lower-potency hemp edibles, and hemp-derived 
51.10 	consumer products to customers at a cannabis event.
51.11 	(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
51.12 	lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must 
51.13 	take place in a retail area as designated in the premises diagram.
51.14 	(c) Authorized retailers may only conduct sales within their specifically assigned area.
51.15 	(d) Authorized retailers must verify the age of all customers pursuant to section 342.27, 
51.16 	subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis 
51.17 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
51.18 	products to an individual under 21 years of age.
51.19 	(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use 
51.20 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived 
51.21 	consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis 
51.22 	products must be stored in a sample jar or display case and be accompanied by a label or 
51.23 	notice containing the information required to be affixed to the packaging or container 
51.24 	containing adult-use cannabis flower and adult-use cannabis products sold to customers. A 
51.25 	sample may not consist of more than eight grams of adult-use cannabis flower or adult-use 
51.26 	cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams 
51.27 	of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use 
51.28 	cannabis flower or adult-use cannabis product before purchase.
51.29 	(f) The notice requirements under section 342.27, subdivision 6, apply to authorized 
51.30 	retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products, 
51.31 	and hemp-derived consumer products for sale at a cannabis event.
51.32 	(g) Authorized retailers may not:
52.1 	(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
52.2 	edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
52.3 	(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis 
52.4 	products, lower-potency hemp edibles, or hemp-derived consumer products than a customer 
52.5 	is legally permitted to possess;
52.6 	(3) sell medical cannabis flower or medical cannabinoid products; or
52.7 	(4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp 
52.8 	edibles, or hemp-derived consumer products; or
52.9 	(5) (4) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
52.10 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
52.11 	(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis 
52.12 	product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis 
52.13 	plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles, 
52.14 	and hemp-derived consumer products for sale at a cannabis event must be stored in a secure, 
52.15 	locked container that is not accessible to the public. Such items being stored at a cannabis 
52.16 	event shall not be left unattended.
52.17 	(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
52.18 	lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis 
52.19 	event must comply with this chapter and rules adopted pursuant to this chapter regarding 
52.20 	the testing, packaging, and labeling of those items.
52.21 	(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold, 
52.22 	damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring 
52.23 	system.

52.24 	Sec. 68. Minnesota Statutes 2024, section 342.40, is amended by adding a subdivision to 
52.25 	read:
52.26 		Subd. 7a.Cannabis sample products. (a) Notwithstanding any other provisions of law, 
52.27 	a retailer authorized to make sales to customers pursuant to subdivision 7 may give away 
52.28 	samples of cannabis plants, cannabis flower, cannabis products, lower-potency hemp edibles, 
52.29 	or hemp-derived consumer products during a cannabis event. A label or notice containing 
52.30 	the information required to be affixed to the packaging or container containing cannabis 
52.31 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
52.32 	products sold to customers must be displayed and available for consumers.
53.1 	(b) Products given away as samples must not consist of more than:
53.2 	(1) one gram of adult-use cannabis flower or adult-use cannabis concentrate;
53.3 	(2) ten milligrams of tetrahydrocannabinol infused in an edible cannabis product; and
53.4 	(3) five milligrams of delta-9 tetrahydrocannabinol, 100 milligrams of cannabidiol, 
53.5 	cannabigerol, cannabinol, or cannabichromene, or any combination of those cannabinoids 
53.6 	that does not exceed the identified amounts in a lower-potency hemp edible.
53.7 	(c) Authorized retailers must not give away samples to an individual who is visibly 
53.8 	intoxicated.
53.9 	(d) Samples of any cannabis plants, cannabis flower, cannabis products, and hemp-derived 
53.10 	consumer products that are required to be entered into the statewide monitoring system 
53.11 	must be documented in the statewide monitoring system.

53.12 	Sec. 69. Minnesota Statutes 2024, section 342.43, subdivision 1, is amended to read:
53.13 		Subdivision 1.License types. The office shall issue the following types of hemp business 
53.14 	licenses:
53.15 	(1) lower-potency hemp edible manufacturer; and
53.16 	(2) lower-potency hemp edible wholesaler; and
53.17 	(2) (3) lower-potency hemp edible retailer.

53.18 	Sec. 70. Minnesota Statutes 2024, section 342.43, subdivision 2, is amended to read:
53.19 		Subd. 2.Multiple licenses; limits. (a) A person, cooperative, or business may hold both
53.20 	any combination of a lower-potency hemp edible manufacturer, a lower-potency hemp 
53.21 	edible wholesaler, and a lower-potency hemp edible retailer license.
53.22 	(b) Nothing in this section prohibits a person, cooperative, or business from holding a 
53.23 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
53.24 	license, a lower-potency hemp edible retailer license, or both any combination of those 
53.25 	licenses, and also holding a license to cultivate industrial hemp issued pursuant to chapter 
53.26 	18K.
53.27 	(c) Nothing in this section prohibits a person, cooperative, or business from holding a 
53.28 	lower-potency hemp edible manufacturer license, a lower-potency hemp edible wholesaler 
53.29 	license, a lower-potency hemp edible retailer license, or both any combination of those 
53.30 	licenses, and also holding any other license, including but not limited to a license to prepare 
54.1 	or sell food; sell tobacco, tobacco-related devices, electronic delivery devices as defined in 
54.2 	section 609.685, subdivision 1, and nicotine and lobelia delivery products as described in 
54.3 	section 609.6855; or manufacture or sell alcoholic beverages as defined in section 340A.101, 
54.4 	subdivision 2.
54.5 	(d) A person, cooperative, or business holding a lower-potency hemp edible manufacturer 
54.6 	license, a lower-potency hemp edible wholesaler license, a lower-potency hemp edible 
54.7 	retailer license, or both any combination of those licenses, may not hold a cannabis business 
54.8 	license.

54.9 	Sec. 71. Minnesota Statutes 2024, section 342.43, is amended by adding a subdivision to 
54.10 	read:
54.11 		Subd. 3.Exception; municipal or county licenses. Notwithstanding any law to the 
54.12 	contrary, a city or county that establishes, owns, or operates a municipal cannabis store may 
54.13 	also hold a lower-potency hemp edible retailer license.

54.14 	Sec. 72. Minnesota Statutes 2024, section 342.44, subdivision 1, is amended to read:
54.15 		Subdivision 1.Application; contents. (a) Except as otherwise provided in this 
54.16 	subdivision, the provisions of this chapter relating to license applications, license selection 
54.17 	criteria, general ownership disqualifications and requirements, and general operational 
54.18 	requirements do not apply to hemp businesses.
54.19 	(b) The office, by rule, shall establish forms and procedures for the processing of hemp 
54.20 	licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp 
54.21 	license shall include the following information, if applicable:
54.22 	(1) the name, address, and date of birth of the applicant;
54.23 	(2) the address and legal property description of the business;
54.24 	(3) proof of trade name registration;
54.25 	(4) certification that the applicant will comply with the requirements of this chapter 
54.26 	relating to the ownership and operation of a hemp business;
54.27 	(5) identification of one or more controlling persons or managerial employees as agents 
54.28 	who shall be responsible for dealing with the office on all matters; and
54.29 	(6) a statement that the applicant agrees to respond to the office's supplemental requests 
54.30 	for information.
55.1 	(c) An applicant for a lower-potency hemp edible manufacturer license must submit an 
55.2 	attestation signed by a bona fide labor organization stating that the applicant has entered 
55.3 	into a labor peace agreement. A labor peace agreement entered into on or after August 15, 
55.4 	2025, must address the duration of the election.
55.5 	(d) An application on behalf of a corporation or association shall be signed by at least 
55.6 	two officers or managing agents of that entity.

55.7 	Sec. 73. Minnesota Statutes 2024, section 342.45, subdivision 1, is amended to read:
55.8 		Subdivision 1.Authorized actions. A lower-potency hemp edible manufacturer license, 
55.9 	consistent with the specific license endorsement or endorsements, entitles the license holder 
55.10 	to:
55.11 	(1) purchase hemp plant parts, hemp concentrate, and artificially derived cannabinoids 
55.12 	from cannabis microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, cannabis 
55.13 	wholesalers, and lower-potency hemp edible manufacturers;
55.14 	(2) purchase hemp plant parts and propagules from industrial hemp growers licensed 
55.15 	under chapter 18K;
55.16 	(3) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
55.17 	18K;
55.18 	(4) make hemp concentrate;
55.19 	(5) manufacture artificially derived cannabinoids;
55.20 	(6) manufacture lower-potency hemp edibles for public consumption;
55.21 	(7) package and label lower-potency hemp edibles for sale to customers;
55.22 	(8) sell hemp concentrate, artificially derived cannabinoids, and lower-potency hemp 
55.23 	edibles to other cannabis businesses and hemp businesses; and
55.24 	(9) manufacture, package, and label products containing cannabinoids that are intended 
55.25 	for sale outside of the state;
55.26 	(10) store products containing cannabinoids that are intended for sale outside of the 
55.27 	state;
55.28 	(11) sell products containing cannabinoids that do not qualify as lower-potency hemp 
55.29 	edibles but are compliant with the importing state's requirements to customers outside of 
55.30 	the state; and
55.31 	(9) (12) perform other actions approved by the office.

56.1 	Sec. 74. Minnesota Statutes 2024, section 342.45, is amended by adding a subdivision to 
56.2 	read:
56.3 		Subd. 4a.Products intended for sale in other jurisdictions. (a) A lower-potency hemp 
56.4 	edible manufacturer that produces products containing cannabinoids that do not qualify as 
56.5 	lower-potency hemp edibles and are intended for sale only in jurisdictions other than 
56.6 	Minnesota must obtain a hemp product exporter endorsement from the office.
56.7 	(b) All areas within the premises of a lower-potency hemp edible manufacturer used for 
56.8 	producing products containing cannabinoids that do not qualify as lower-potency hemp 
56.9 	edibles must meet the sanitary standards specified in rules adopted by the office.
56.10 	(c) A lower-potency hemp edible manufacturer must not add any cannabis flower, 
56.11 	cannabis concentrate, or cannabinoid derived from cannabis flower or cannabis concentrate 
56.12 	to products containing cannabinoids that do not qualify as lower-potency hemp edibles.
56.13 	(d) All products containing cannabinoids that do not qualify as lower-potency hemp 
56.14 	edibles and are intended, distributed, and offered for sale only in jurisdictions other than 
56.15 	Minnesota must be physically separated from all lower-potency hemp edibles during the 
56.16 	manufacturing, packaging, and labeling process.
56.17 	(e) All products containing cannabinoids that do not qualify as lower-potency hemp 
56.18 	edibles and are intended, distributed, and offered for sale only in jurisdictions other than 
56.19 	Minnesota must be tested as provided in section 342.61 and must meet all standards 
56.20 	established by the office except for any limits on the amount of any cannabinoid a product 
56.21 	may contain. The packaging of such products must contain verification that the product was 
56.22 	tested according to section 342.61 and that the product complies with applicable standards 
56.23 	except for any limits on the amount of any cannabinoid a product may contain. The packaging 
56.24 	must also include the product's batch number and the cannabinoid profile per serving and 
56.25 	in total.
56.26 	(f) The packaging of all products containing cannabinoids that do not qualify as 
56.27 	lower-potency hemp edibles and are intended, distributed, and offered for sale only in 
56.28 	jurisdictions other than Minnesota must clearly state that the products are not for sale in 
56.29 	Minnesota.
56.30 	(g) A lower-potency hemp edible manufacturer may only sell or offer for sale products 
56.31 	containing cannabinoids to customers outside of the state if the products are compliant with 
56.32 	the importing state's requirements.
57.1 	(h) A lower-potency hemp edible manufacturer must not sell or offer for sale products 
57.2 	containing cannabinoids that do not qualify as lower-potency hemp edibles in Minnesota 
57.3 	and must not manufacture, distribute, or store such products knowing or having reason to 
57.4 	know that the products will be sold in Minnesota. A lower-potency hemp edible manufacturer 
57.5 	selling such products must ensure that the products are not sold in Minnesota by notifying 
57.6 	the distributor, wholesaler, retail business, or other person purchasing a product that sale 
57.7 	of the products in Minnesota could result in the imposition of civil or criminal penalties and 
57.8 	in the termination of any contract between the lower-potency hemp edible manufacturer 
57.9 	and the distributor, wholesaler, retail business, or other person purchasing the product.
57.10 	(i) The office may suspend, revoke, or cancel the license or endorsement of a 
57.11 	lower-potency hemp edible manufacturer who is prohibited from distributing products 
57.12 	containing cannabinoids in any other jurisdiction, convicted of an offense involving the 
57.13 	distribution of products containing cannabinoids in any other jurisdiction, or found liable 
57.14 	for distributing any product that injured customers in any other jurisdiction. A lower-potency 
57.15 	hemp edible manufacturer shall disclose all relevant information related to actions in another 
57.16 	jurisdiction. Failure to disclose relevant information may result in disciplinary action by 
57.17 	the office, including the suspension, revocation, or cancellation of an endorsement or license.

57.18 	Sec. 75. Minnesota Statutes 2024, section 342.45, is amended by adding a subdivision to 
57.19 	read:
57.20 		Subd. 6.Building conditions. (a) A lower-potency hemp edible manufacturer must 
57.21 	comply with state and local building, fire, and zoning codes, requirements, and regulations.
57.22 	(b) A lower-potency hemp edible manufacturer must ensure that licensed premises are 
57.23 	maintained in a clean and sanitary condition and are free from infestation by insects, rodents, 
57.24 	or other pests.

57.25 	Sec. 76. [342.455] LOWER-POTENCY HEMP EDIBLE WHOLESALER.
57.26 		Subdivision 1.Authorized actions. A lower-potency hemp edible wholesaler license, 
57.27 	consistent with the specific license endorsement or endorsements, entitles the license holder 
57.28 	to perform any or all of the following within the limits established by this section:
57.29 	(1) purchase lower-potency hemp edibles from cannabis microbusinesses, cannabis 
57.30 	mezzobusinesses, cannabis cultivators, cannabis manufacturers, cannabis wholesalers, other 
57.31 	lower-potency hemp edible wholesalers, and lower-potency hemp edible manufacturers;
58.1 	(2) sell lower-potency hemp edibles to lower-potency hemp edible retailers with a retail 
58.2 	endorsement, cannabis microbusinesses with a retail endorsement, cannabis mezzobusinesses 
58.3 	with a retail endorsement, cannabis retailers, cannabis wholesalers, medical cannabis 
58.4 	combination businesses, and other lower-potency hemp edible wholesalers;
58.5 	(3) import lower-potency hemp edibles that contain hemp concentrate or artificially 
58.6 	derived cannabinoids that are derived from hemp plants or hemp plant parts;
58.7 	(4) purchase and store products containing cannabinoids that are intended for sale outside 
58.8 	of the state;
58.9 	(5) sell products containing cannabinoids that do not qualify as lower-potency hemp 
58.10 	edibles to customers outside of the state; and
58.11 	(6) perform other actions approved by the office.
58.12 		Subd. 2.Operations; physical presence. (a) A lower-potency hemp edible wholesaler 
58.13 	must maintain accurate records and ensure that appropriate labels remain affixed to 
58.14 	lower-potency hemp edibles.
58.15 	(b) A lower-potency hemp edible wholesaler must maintain compliance with state and 
58.16 	local building, fire, and zoning requirements or regulations and must ensure that the 
58.17 	wholesaler's premises are maintained in a clean and sanitary condition, free from infestation 
58.18 	by insects, rodents, or other pests.
58.19 	(c) A lower-potency hemp edible wholesaler may purchase and sell other products or 
58.20 	items for which the wholesaler has a license or an authorization or that do not require a 
58.21 	license or an authorization. Products for which no license or authorization is required include 
58.22 	but are not limited to industrial hemp products, products that contain hemp grain, 
58.23 	hemp-derived topical products, and cannabis paraphernalia. Cannabis paraphernalia includes 
58.24 	but is not limited to childproof packaging containers and other devices designed to ensure 
58.25 	the safe storage and monitoring of cannabis flower and cannabis products in the home to 
58.26 	prevent access by individuals under 21 years of age.
58.27 	(d) A lower-potency hemp edible wholesaler must own or lease warehouse or office 
58.28 	space within the state.
58.29 		Subd. 3.Importation of lower-potency hemp edibles; endorsement. (a) A 
58.30 	lower-potency hemp edible wholesaler that imports lower-potency hemp edibles that are 
58.31 	manufactured outside the boundaries of the state of Minnesota with the intent to sell the 
58.32 	products to a cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, cannabis 
58.33 	wholesaler, medical cannabis combination business, other lower-potency hemp edible 
59.1 	wholesaler, or lower-potency hemp edible retailer must obtain a lower-potency hemp edible 
59.2 	importer endorsement from the office.
59.3 	(b) A lower-potency hemp edible wholesaler with an endorsement issued under this 
59.4 	subdivision may sell products manufactured outside the boundaries of the state of Minnesota 
59.5 	if:
59.6 	(1) the manufacturer is licensed in another jurisdiction and subject to regulations designed 
59.7 	to protect the health and safety of consumers that the office determines are substantially 
59.8 	similar to the regulations in this state; or
59.9 	(2) the lower-potency hemp edible wholesaler establishes, to the satisfaction of the office, 
59.10 	that the manufacturer engages in practices that are substantially similar to the practices 
59.11 	required for licensure of manufacturers in this state.
59.12 	(c) The office may suspend, revoke, or cancel the license or endorsement of a wholesaler 
59.13 	who is prohibited from distributing products containing cannabinoids in any other jurisdiction, 
59.14 	convicted of an offense involving the distribution of products containing cannabinoids in 
59.15 	any other jurisdiction, or found liable for distributing any product that injured customers in 
59.16 	any other jurisdiction. A lower-potency hemp edible wholesaler shall disclose all relevant 
59.17 	information related to actions in another jurisdiction. Failure to disclose relevant information 
59.18 	may result in disciplinary action by the office, including the suspension, revocation, or 
59.19 	cancellation of an endorsement or license.
59.20 	(d) Notwithstanding any law to the contrary, it is not a defense in any civil or criminal 
59.21 	action that a wholesaler relied on information on a product label or otherwise provided by 
59.22 	a manufacturer who is not licensed in this state.
59.23 		Subd. 4.Products intended for sale in other jurisdictions. (a) A lower-potency hemp 
59.24 	edible wholesaler that purchases, stores, transports, or sells products containing cannabinoids 
59.25 	that do not qualify as lower-potency hemp edibles and are intended for sale only in 
59.26 	jurisdictions other than Minnesota must obtain a hemp product exporter endorsement from 
59.27 	the office.
59.28 	(b) All products containing cannabinoids that do not qualify as lower-potency hemp 
59.29 	edibles and are intended, distributed, and offered for sale only in jurisdictions other than 
59.30 	Minnesota must be physically separated from all lower-potency hemp edibles and must be 
59.31 	in packaging that clearly states that the products are not for sale in Minnesota.
59.32 	(c) All products containing cannabinoids that do not qualify as lower-potency hemp 
59.33 	edibles and are intended, distributed, and offered for sale only in jurisdictions other than 
60.1 	Minnesota must be packaged in a manner that includes verification that the product was 
60.2 	tested according to section 342.61 and that the product complies with applicable standards 
60.3 	except for any limits on the amount of any cannabinoid a product may contain. The packaging 
60.4 	must also include the product's batch number and the cannabinoid profile per serving and 
60.5 	in total.
60.6 	(d) A lower-potency hemp edible wholesaler must not sell or offer for sale products 
60.7 	containing cannabinoids that do not qualify as lower-potency hemp edibles in Minnesota 
60.8 	and must not distribute or store such products knowing or having reason to know that the 
60.9 	products will be sold in Minnesota.
60.10 	(e) The office may suspend, revoke, or cancel the license or endorsement of a 
60.11 	lower-potency hemp edible wholesaler who is prohibited from distributing products 
60.12 	containing cannabinoids in any other jurisdiction, convicted of an offense involving the 
60.13 	distribution of products containing cannabinoids in any other jurisdiction, or found liable 
60.14 	for distributing any product that injured customers in any other jurisdiction. A lower-potency 
60.15 	hemp edible wholesaler shall disclose all relevant information related to actions in another 
60.16 	jurisdiction. Failure to disclose relevant information may result in disciplinary action by 
60.17 	the office, including the suspension, revocation, or cancellation of an endorsement or license.
60.18 		Subd. 5.Transportation of lower-potency hemp edibles; endorsement. (a) A 
60.19 	lower-potency hemp edible wholesaler that transports lower-potency hemp edibles to a 
60.20 	cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, cannabis wholesaler, 
60.21 	medical cannabis combination business, different lower-potency hemp edible wholesaler, 
60.22 	or lower-potency hemp edible retailer must obtain a lower-potency hemp edible transporter 
60.23 	endorsement from the office.
60.24 	(b) In addition to the information required to be submitted under section 342.44, 
60.25 	subdivision 1, and rules adopted pursuant to that section, a person, cooperative, or business 
60.26 	seeking a lower-potency hemp edible transporter endorsement must submit the following 
60.27 	information in a form approved by the office:
60.28 	(1) an appropriate surety bond, a certificate of insurance, qualifications as a self-insurer, 
60.29 	or other securities or agreements, in the amount of not less than $300,000, for loss of or 
60.30 	damage to cargo;
60.31 	(2) an appropriate surety bond, a certificate of insurance, qualifications as a self-insurer, 
60.32 	or other securities or agreements, in the amount of not less than $1,000,000, for injury to 
60.33 	one or more persons in any one accident and, if an accident has resulted in injury to or 
61.1 	destruction of property, of not less than $100,000 because of such injury to or destruction 
61.2 	of property of others in any one accident;
61.3 	(3) the number and type of equipment the business will use to transport lower-potency 
61.4 	hemp edibles;
61.5 	(4) a loading, transporting, and unloading plan;
61.6 	(5) a description of the applicant's experience in the distribution or security business; 
61.7 	and
61.8 	(6) evidence that the business will comply with the applicable operation requirements 
61.9 	for the license being sought.
61.10 	(c) A lower-potency hemp edible wholesaler may transport lower-potency hemp edibles 
61.11 	on public roadways if:
61.12 	(1) the lower-potency hemp edibles are in a locked, safe, and secure storage compartment 
61.13 	that is part of the motor vehicle or in a locked storage container that has a separate key or 
61.14 	combination pad;
61.15 	(2) the lower-potency hemp edibles are packaged in tamper-evident containers that are 
61.16 	not visible or recognizable from outside the transporting vehicle;
61.17 	(3) the lower-potency hemp edible wholesaler has a shipping manifest in the wholesaler's 
61.18 	possession that describes the contents of all tamper-evident containers;
61.19 	(4) all departures, arrivals, and stops are appropriately documented;
61.20 	(5) no person other than a designated employee enters a vehicle at any time that the 
61.21 	vehicle is transporting lower-potency hemp edibles;
61.22 	(6) at all times that the vehicle contains lower-potency hemp edibles, the vehicle is (i) 
61.23 	secured by turning off the ignition, locking all doors and storage compartments, and removing 
61.24 	the operating keys or device, or (ii) attended by a lower-potency hemp edible wholesaler 
61.25 	employee; and
61.26 	(7) the lower-potency hemp edible wholesaler complies with any other rules adopted 
61.27 	by the office related to the transportation of lower-potency hemp edibles by a lower-potency 
61.28 	hemp edible wholesaler, except that rules requiring a lower-potency hemp edible wholesaler 
61.29 	to randomize delivery times and routes or staff vehicles with multiple employees do not 
61.30 	apply.
61.31 	(d) Any vehicle assigned for the purposes of transporting lower-potency hemp edibles 
61.32 	is subject to inspection at any time.

62.1 	Sec. 77. Minnesota Statutes 2024, section 342.46, subdivision 1, is amended to read:
62.2 		Subdivision 1.Sale of lower-potency hemp edibles Authorized actions. (a) A 
62.3 	lower-potency hemp edible retailer may only sell lower-potency hemp edibles to individuals 
62.4 	who are at least 21 years of age. license, consistent with the specific license endorsement 
62.5 	or endorsements, entitles the license holder to perform any or all of the following within 
62.6 	the limits established by this section:
62.7 	(b) A lower-potency hemp edible retailer may sell lower-potency hemp edibles that:
62.8 	(1) are obtained purchase lower-potency hemp edibles from a licensed Minnesota cannabis 
62.9 	microbusiness, cannabis mezzobusiness, cannabis manufacturer, cannabis wholesaler, 
62.10 	medical cannabis combination business, or lower-potency hemp edible manufacturer, or 
62.11 	lower-potency hemp edible wholesaler; and
62.12 	(2) meet all applicable packaging and labeling requirements sell lower-potency hemp 
62.13 	edibles that meet all packaging and labeling requirements to customers who are at least 21 
62.14 	years of age;
62.15 	(3) transport and deliver lower-potency hemp edibles to customers; and
62.16 	(4) perform other actions approved by the office.

62.17 	Sec. 78. Minnesota Statutes 2024, section 342.46, is amended by adding a subdivision to 
62.18 	read:
62.19 		Subd. 1a.Retailer operations endorsement. In addition to the information required to 
62.20 	be submitted under section 342.44, subdivision 1, a lower-potency hemp edible retailer that 
62.21 	intends to operate a retail establishment must indicate that intent in the form and manner 
62.22 	approved by the office.

62.23 	Sec. 79. Minnesota Statutes 2024, section 342.46, is amended by adding a subdivision to 
62.24 	read:
62.25 		Subd. 1b.Delivery endorsement. (a) In addition to the information required to be 
62.26 	submitted under section 342.44, subdivision 1, a lower-potency hemp edible retailer that 
62.27 	delivers lower-potency hemp edibles must submit the following information in a form 
62.28 	approved by the office:
62.29 	(1) proof of insurance for each vehicle or general liability insurance with a limit of at 
62.30 	least $1,000,000 for each occurrence;
63.1 	(2) a business plan demonstrating policies to avoid sales of lower-potency hemp edibles 
63.2 	to individuals who are under 21 years of age; and
63.3 	(3) evidence that the business will comply with the applicable operation requirements 
63.4 	for the license being sought.
63.5 	(b) A lower-potency hemp edible retailer with a delivery endorsement:
63.6 	(1) must ensure that lower-potency hemp edibles are not visible from outside the delivery 
63.7 	vehicle;
63.8 	(2) must ensure that a vehicle that contains lower-potency hemp edibles is (i) secured 
63.9 	by turning off the ignition, locking all doors and storage compartments, and removing the 
63.10 	operating keys or device, or (ii) attended by a lower-potency hemp edible retailer employee 
63.11 	or independent contractor acting on behalf of the lower-potency hemp edible retailer; and
63.12 	(3) must not use a vehicle or trailer with an image depicting the types of items being 
63.13 	transported, including but not limited to an image depicting a cannabis or hemp leaf, or a 
63.14 	name suggesting that the delivery vehicle is used for transporting lower-potency hemp 
63.15 	edibles.
63.16 	(c) Any vehicle delivering lower-potency hemp edibles is subject to inspection at any 
63.17 	time.
63.18 	(d) The office may, by policy, establish limits on the amount of lower-potency hemp 
63.19 	edibles that a single delivery vehicle may transport at any time. If the office establishes 
63.20 	limits under this paragraph, the office must notify all lower-potency hemp edible retailers 
63.21 	with a delivery endorsement of the limit and must post the limit on the office's publicly 
63.22 	accessible website.

63.23 	Sec. 80. Minnesota Statutes 2024, section 342.46, subdivision 3, is amended to read:
63.24 		Subd. 3.Age verification. Prior to initiating a sale or completing a delivery, an employee 
63.25 	or independent contractor of the lower-potency hemp edible retailer must verify that the 
63.26 	customer is at least 21 years of age. Section 342.27, subdivision 4, applies to the verification 
63.27 	of a customer's age.

63.28 	Sec. 81. Minnesota Statutes 2024, section 342.46, subdivision 4, is amended to read:
63.29 		Subd. 4.Display and storage of lower-potency hemp edibles. A lower-potency hemp 
63.30 	edible retailer operating a retail location shall ensure that all lower-potency hemp edibles, 
63.31 	other than lower-potency hemp edibles that are intended to be consumed as a beverage, are 
64.1 	displayed behind a checkout counter where the public is not permitted or in a locked case. 
64.2 	All lower-potency hemp edibles that are not displayed must be stored in a secure area.

64.3 	Sec. 82. Minnesota Statutes 2024, section 342.46, subdivision 5, is amended to read:
64.4 		Subd. 5.Transportation of lower-potency hemp edibles. (a) A lower-potency hemp 
64.5 	edible retailer may transport lower-potency hemp edibles on public roadways provided:
64.6 	(1) the lower-potency hemp edibles are in final packaging;
64.7 	(2) the lower-potency hemp edibles are packaged in tamper-evident containers that are 
64.8 	not visible or recognizable from outside the transporting vehicle;
64.9 	(3) the lower-potency hemp edible retailer has a shipping manifest in the lower-potency 
64.10 	hemp edible retailer's possession that describes the contents of all tamper-evident containers;
64.11 	(4) all departures, arrivals, and stops are appropriately documented;
64.12 	(5) no person other than a designated employee enters a vehicle at any time that the 
64.13 	vehicle is transporting lower-potency hemp edibles; and
64.14 	(6) the lower-potency hemp edible retailer complies with any other rules adopted by the 
64.15 	office, except that rules requiring a lower-potency hemp edible retailer to randomize delivery 
64.16 	times and routes or staff vehicles with multiple employees do not apply.
64.17 	(b) Any vehicle assigned for the purposes of transporting lower-potency hemp edibles 
64.18 	is subject to inspection at any time.
64.19 	(c) The requirements under paragraph (a) do not apply to the delivery of lower-potency 
64.20 	hemp edibles to customers by a lower-potency hemp edible retailer with a delivery 
64.21 	endorsement.

64.22 	Sec. 83. Minnesota Statutes 2024, section 342.46, subdivision 6, is amended to read:
64.23 		Subd. 6.Compliant products. (a) A lower-potency hemp edible retailer shall ensure 
64.24 	that all lower-potency hemp edibles products containing cannabinoids offered for sale 
64.25 	qualify as hemp-derived topical products or lower-potency hemp edibles and comply with 
64.26 	the all applicable limits on the amount and types of cannabinoids that a lower-potency hemp 
64.27 	edible the product can contain, including but not limited to the requirement that lower-potency 
64.28 	hemp edibles:.
64.29 	(1) consist of servings that contain no more than five milligrams of delta-9 
64.30 	tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams 
65.1 	of cannabigerol, or any combination of those cannabinoids that does not exceed the identified 
65.2 	amounts;
65.3 	(2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids 
65.4 	per serving; and
65.5 	(3) do not contain an artificially derived cannabinoid other than delta-9 
65.6 	tetrahydrocannabinol.
65.7 	(b) If a lower-potency hemp edible is packaged in a manner that includes more than a 
65.8 	single serving, the lower-potency hemp edible must indicate each serving by scoring, 
65.9 	wrapping, or other indicators that appear on the lower-potency hemp edible designating the 
65.10 	individual serving size. If it is not possible to indicate a single serving by scoring or use of 
65.11 	another indicator that appears on the product, the lower-potency hemp edible may not be 
65.12 	packaged in a manner that includes more than a single serving in each container, except 
65.13 	that a calibrated dropper, measuring spoon, or similar device for measuring a single serving 
65.14 	may be used for any edible cannabinoid products that are intended to be combined with 
65.15 	food or beverage products prior to consumption. If the lower-potency hemp edible is meant 
65.16 	to be consumed as a beverage, the beverage container may not contain more than two 
65.17 	servings per container.
65.18 	(c) A single package containing multiple servings of a lower-potency hemp edible must 
65.19 	contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams of 
65.20 	cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids that 
65.21 	does not exceed the identified amounts.

65.22 	Sec. 84. Minnesota Statutes 2024, section 342.46, subdivision 7, is amended to read:
65.23 		Subd. 7.Prohibitions. A lower-potency hemp edible retailer may must not:
65.24 	(1) sell or deliver lower-potency hemp edibles to an individual who is under 21 years 
65.25 	of age;
65.26 	(2) sell or deliver a lower-potency hemp edible to a person who is visibly intoxicated;
65.27 	(3) sell or deliver cannabis flower, cannabis products, or hemp-derived consumer 
65.28 	products;
65.29 	(4) allow for the dispensing of lower-potency hemp edibles in vending machines; or
65.30 	(5) distribute or allow free samples of lower-potency hemp edibles except when the 
65.31 	business is licensed to permit on-site consumption and samples are consumed within its 
65.32 	licensed premises.

66.1 	Sec. 85. Minnesota Statutes 2024, section 342.46, subdivision 8, is amended to read:
66.2 		Subd. 8.On-site consumption. (a) A lower-potency hemp edible retailer may permit 
66.3 	on-site consumption of lower-potency hemp edibles on a portion of its premises if it has an 
66.4 	on-site consumption endorsement.
66.5 	(b) The office shall issue an on-site consumption endorsement to any lower-potency 
66.6 	hemp edible retailer that also holds an on-sale license issued under chapter 340A.
66.7 	(c) A lower-potency hemp edible retailer must ensure that lower-potency hemp edibles 
66.8 	sold for on-site consumption comply with this chapter and rules adopted pursuant to this 
66.9 	chapter regarding testing.
66.10 	(d) Lower-potency hemp edibles sold for on-site consumption, other than lower-potency 
66.11 	hemp edibles that are intended to be consumed as a beverage, must be served in the required 
66.12 	packaging, but may be removed from the products' packaging by customers and consumed 
66.13 	on site.
66.14 	(e) Lower-potency hemp edibles that are intended to be consumed as a beverage may 
66.15 	be served outside of the edibles' packaging if the information that is required to be contained 
66.16 	on the label of a lower-potency hemp edible is posted or otherwise displayed by the 
66.17 	lower-potency hemp edible retailer. Hemp workers who serve beverages under this paragraph 
66.18 	are not required to obtain an edible cannabinoid product handler endorsement under section 
66.19 	342.07, subdivision 3.
66.20 	(f) Food and beverages not otherwise prohibited by this subdivision may be prepared 
66.21 	and sold on site if the lower-potency hemp edible retailer complies with all relevant state 
66.22 	and local laws, ordinances, licensing requirements, and zoning requirements.
66.23 	(g) A lower-potency hemp edible retailer may offer recorded or live entertainment if the 
66.24 	lower-potency hemp edible retailer complies with all relevant state and local laws, ordinances, 
66.25 	licensing requirements, and zoning requirements.
66.26 	(h) In addition to the prohibitions under subdivision 7, a lower-potency hemp edible 
66.27 	retailer with an on-site consumption endorsement may not:
66.28 	(1) sell, give, furnish, or in any way procure for another lower-potency hemp edibles 
66.29 	for the use of an obviously intoxicated person;
66.30 	(2) sell lower-potency hemp edibles that are designed or reasonably expected to be mixed 
66.31 	with an alcoholic beverage; or
67.1 	(3) permit lower-potency hemp edibles that have been removed from the products' 
67.2 	packaging to be removed from the premises of the lower-potency hemp edible retailer.
67.3 	(i) A lower-potency hemp edible retailer is permitted to sell and may permit the 
67.4 	consumption of lower-potency hemp edibles that are intended to be consumed as a beverage 
67.5 	at an event hosted off site if:
67.6 	(1) the event has been authorized by the local unit of government exercising jurisdiction 
67.7 	over the location;
67.8 	(2) the event organizer holds an on-sale license issued under chapter 340A; and
67.9 	(3) the event does not exceed four days.

67.10 	Sec. 86. Minnesota Statutes 2024, section 342.46, subdivision 9, is amended to read:
67.11 		Subd. 9.Posting of notices. A lower-potency hemp edible retailer with a retail 
67.12 	endorsement must post all notices as provided in section 342.27, subdivision 6.

67.13 	Sec. 87. Minnesota Statutes 2024, section 342.51, subdivision 2, is amended to read:
67.14 		Subd. 2.Distribution requirements. (a) Prior to distribution of medical cannabis flower 
67.15 	or medical cannabinoid products to a person enrolled in the registry program, an employee 
67.16 	with a valid medical cannabis consultant certificate issued by the office or a licensed 
67.17 	pharmacist under chapter 151 of a cannabis business must:
67.18 	(1) review and confirm the patient's enrollment in the registry program;
67.19 	(2) verify that the person requesting the distribution of medical cannabis flower or 
67.20 	medical cannabinoid products is the patient, the patient's registered designated caregiver, 
67.21 	or the patient's parent, legal guardian, or spouse using the procedures established by the 
67.22 	office;
67.23 	(3) provide confirm that the patient had a consultation to the patient with (i) an employee 
67.24 	with a valid medical cannabis consultant certificate issued by the office; or (ii) an employee 
67.25 	who is a licensed pharmacist under chapter 151 to determine the proper medical cannabis 
67.26 	flower or medical cannabinoid product, dosage, and paraphernalia for the patient if required 
67.27 	under subdivision 3;
67.28 	(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid 
67.29 	product that includes recommended dosage requirements and other information as required 
67.30 	by the office; and
67.31 	(5) provide the patient with any other information required by the office.
68.1 	(b) A cannabis business with a medical cannabis retail endorsement may not deliver 
68.2 	medical cannabis flower or medical cannabinoid products to a person enrolled in the registry 
68.3 	program unless the cannabis business with a medical cannabis retail endorsement also holds 
68.4 	a cannabis delivery service license. The delivery of medical cannabis flower and medical 
68.5 	cannabinoid products are subject to the provisions of section 342.42.

68.6 	Sec. 88. Minnesota Statutes 2024, section 342.51, is amended by adding a subdivision to 
68.7 	read:
68.8 		Subd. 2a.Distribution to visiting patients. (a) A cannabis business with a medical 
68.9 	cannabis retail endorsement may distribute medical cannabis flower or medical cannabinoid 
68.10 	products to a visiting patient.
68.11 	(b) Before receiving a distribution of medical cannabis, a visiting patient must provide 
68.12 	to an employee of the cannabis business:
68.13 	(1) a valid medical cannabis registration verification card or equivalent document issued 
68.14 	under the laws and regulations of another state, district, commonwealth, Tribal Nation, or 
68.15 	territory that indicates that the visiting patient is authorized to use medical cannabis in the 
68.16 	issuing jurisdiction; and
68.17 	(2) a valid photographic identification card issued by the visiting patient's medical 
68.18 	cannabis program, a valid driver's license, or a valid state identification card.
68.19 	(c) Prior to the distribution of medical cannabis flower or medical cannabinoid products 
68.20 	to a visiting patient, an employee of a cannabis business must:
68.21 	(1) ensure that a patient-specific label has been applied to all medical cannabis flower 
68.22 	and medical cannabinoid products. The label must include the recommended dosage 
68.23 	requirements and other information required by the office; and
68.24 	(2) provide the patient with any other information required by the office.
68.25 	(d) For each transaction that involves a visiting patient, a cannabis business with a 
68.26 	medical cannabis retail endorsement must report to the office on a weekly basis:
68.27 	(1) the name of the visiting patient;
68.28 	(2) the name of the medical cannabis program in which the visiting patient is enrolled;
68.29 	(3) the amount and dosages of medical cannabis distributed;
68.30 	(4) the chemical composition of the medical cannabis distributed; and
69.1 	(5) the tracking number assigned to the medical cannabis that was distributed to the 
69.2 	visiting patient.
69.3 	(e) A cannabis business with a medical cannabis retail endorsement may distribute 
69.4 	medical cannabis flower and medical cannabinoid products to a visiting patient in a motor 
69.5 	vehicle if:
69.6 	(1) an employee of the cannabis business receives payment and distributes medical 
69.7 	cannabis flower and medical cannabinoid products in a designated zone that is as close as 
69.8 	feasible to the front door of the facility where the cannabis business is located;
69.9 	(2) the cannabis business with a medical cannabis retail endorsement ensures that the 
69.10 	receipt of payment and distribution of medical cannabis flower and medical cannabinoid 
69.11 	products are visually recorded by a closed-circuit television surveillance camera and provides 
69.12 	any other necessary security safeguards required by the office;
69.13 	(3) the cannabis business with a medical cannabis retail endorsement does not store 
69.14 	medical cannabis flower or medical cannabinoid products outside a restricted access area;
69.15 	(4) an employee of the cannabis business transports medical cannabis flower and medical 
69.16 	cannabinoid products from a restricted access area to the designated zone for distribution 
69.17 	to patients only after confirming that the visiting patient has arrived in the designated zone;
69.18 	(5) the payment for and distribution of medical cannabis flower and medical cannabinoid 
69.19 	products to a patient only occurs after meeting the requirements in paragraph (b);
69.20 	(6) immediately following the distribution of medical cannabis flower or medical 
69.21 	cannabinoid products to a patient, an employee of the cannabis business records the 
69.22 	transaction in the statewide monitoring system; and
69.23 	(7) immediately following the distribution of medical cannabis flower and medical 
69.24 	cannabinoid products, an employee of the cannabis business transports all payments received 
69.25 	into the facility where the cannabis business is located.

69.26 	Sec. 89. Minnesota Statutes 2024, section 342.515, subdivision 1, is amended to read:
69.27 		Subdivision 1.Authorized actions. (a) A person, cooperative, or business holding a 
69.28 	medical cannabis combination business license is prohibited from owning or operating any 
69.29 	other cannabis business or hemp business or holding an active registration agreement under 
69.30 	section 152.25, subdivision 1.
69.31 	(b) A person or business may hold only one medical cannabis combination business 
69.32 	license.
70.1 	(c) A medical cannabis combination business license entitles the license holder to perform 
70.2 	any or all of the following within the limits established by this section:
70.3 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
70.4 	adult-use cannabis flower and medical cannabis flower from a mature plant;
70.5 	(2) make cannabis concentrate;
70.6 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
70.7 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
70.8 	(4) manufacture artificially derived cannabinoids;
70.9 	(5) manufacture medical cannabinoid products;
70.10 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
70.11 	hemp-derived consumer products for public consumption;
70.12 	(7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis 
70.13 	microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler, 
70.14 	or another medical cannabis combination business;
70.15 	(8) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
70.16 	under chapter 18K;
70.17 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
70.18 	from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a 
70.19 	cannabis wholesaler, or another medical cannabis combination business;
70.20 	(10) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
70.21 	18K;
70.22 	(11) manufacture, package, and label medical cannabis flower and medical cannabinoid 
70.23 	products for sale to cannabis businesses with a medical cannabis processor endorsement, 
70.24 	cannabis businesses with a medical cannabis retail endorsement, other medical cannabis 
70.25 	combination businesses, and persons in the registry program;
70.26 	(12) transport and deliver medical cannabis flower and medical cannabinoid products 
70.27 	to medical cannabis processors, medical cannabis retailers, other medical cannabis 
70.28 	combination businesses, patients enrolled in the registry program, registered designated 
70.29 	caregivers, and parents, legal guardians, and spouses of an enrolled patient;
70.30 	(12) (13) manufacture, package, and label adult-use cannabis flower, adult-use cannabis 
70.31 	products, lower-potency hemp edibles, and hemp-derived consumer products for sale to 
70.32 	customers and other cannabis businesses;
71.1 	(13) (14) sell medical cannabis flower and medical cannabinoid products to other cannabis 
71.2 	businesses with a medical endorsement, other medical cannabis combination businesses, 
71.3 	and patients enrolled in the registry program, registered designated caregivers, and parents, 
71.4 	legal guardians, and spouses of an enrolled patient;
71.5 	(14) (15) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
71.6 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
71.7 	other products authorized by law to other cannabis businesses and to customers; and
71.8 	(16) transport immature cannabis plants and seedlings, adult-use cannabis flower, 
71.9 	adult-use cannabis products, lower-potency hemp edibles, hemp-derived consumer products, 
71.10 	and other products authorized by law to other cannabis businesses;
71.11 	(17) sell and transport lower-potency hemp edibles to lower-potency hemp edible retailers 
71.12 	and lower-potency hemp edible wholesalers; and
71.13 	(15) (18) perform other actions approved by the office.
71.14 	(d) A medical cannabis combination business is not required to obtain a medical cannabis 
71.15 	endorsement to perform any actions authorized under this section.

71.16 	Sec. 90. Minnesota Statutes 2024, section 342.515, subdivision 7, is amended to read:
71.17 		Subd. 7.Transportation between facilities. A medical cannabis combination business 
71.18 	may transport immature cannabis plants and seedlings, cannabis flower, cannabis products, 
71.19 	artificially derived cannabinoids, hemp plant parts, hemp concentrate, lower-potency hemp 
71.20 	edibles, and hemp-derived consumer products between facilities operated by the medical 
71.21 	cannabis combination business if the medical cannabis combination business:
71.22 	(1) provides the office with the information described in section 342.35, subdivision 2; 
71.23 	and
71.24 	(2) complies with the requirements of section 342.36.

71.25 	Sec. 91. Minnesota Statutes 2024, section 342.52, is amended by adding a subdivision to 
71.26 	read:
71.27 		Subd. 7a.Allowable delivery methods. A patient in the registry program may receive 
71.28 	medical cannabis flower and medical cannabinoid products. The office may approve 
71.29 	additional delivery methods to expand the types of products that qualify as medical 
71.30 	cannabinoid products.

72.1 	Sec. 92. Minnesota Statutes 2024, section 342.52, subdivision 9, is amended to read:
72.2 		Subd. 9.Registered designated caregiver. (a) The office must register a designated 
72.3 	caregiver for a patient if the patient requires assistance in administering medical cannabis 
72.4 	flower or medical cannabinoid products; obtaining medical cannabis flower, medical 
72.5 	cannabinoid products, or medical cannabis paraphernalia from a cannabis business with a 
72.6 	medical cannabis retail endorsement; or cultivating cannabis plants as permitted by section 
72.7 	342.09, subdivision 2.
72.8 	(b) In order to serve as a designated caregiver, a person must:
72.9 	(1) be at least 18 years of age;
72.10 	(2) agree to only possess the patient's medical cannabis flower and medical cannabinoid 
72.11 	products for purposes of assisting the patient; and
72.12 	(3) agree that if the application is approved, the person will not serve as a registered 
72.13 	designated caregiver for more than six registered patients at one time. Patients who reside 
72.14 	in the same residence count as one patient.
72.15 	(c) Nothing in this section shall be construed to prevent a registered designated caregiver 
72.16 	from being enrolled in the registry program as a patient and possessing and administering 
72.17 	medical cannabis flower or medical cannabinoid products as a patient.
72.18 	(d) Notwithstanding any law to the contrary, a registered designated caregiver approved 
72.19 	to assist a patient enrolled in the registry program with obtaining medical cannabis flower 
72.20 	may cultivate cannabis plants on behalf of one patient. A registered designated caregiver 
72.21 	may grow up to eight cannabis plants for the patient household that the registered designated 
72.22 	caregiver is approved to assist with obtaining medical cannabis flower. If a patient enrolled 
72.23 	in the registry program directs the patient's registered designated caregiver to cultivate 
72.24 	cannabis plants on behalf of the patient, the patient must assign the patient's right to cultivate 
72.25 	cannabis plants to the registered designated caregiver and the notify the office. A patient 
72.26 	who assigns the patient's right to cultivate cannabis plants to a registered caregiver is 
72.27 	prohibited from cultivating cannabis plants for personal use. Nothing in this paragraph limits 
72.28 	the right of a registered designated caregiver cultivating cannabis plants on behalf of a 
72.29 	patient enrolled in the registry program to also cultivate cannabis plants for personal use 
72.30 	pursuant to section 342.09, subdivision 2.

72.31 	Sec. 93. Minnesota Statutes 2024, section 342.56, subdivision 2, is amended to read:
72.32 		Subd. 2.Health care facilities. (a) Health care facilities licensed under chapter 144A; 
72.33 	hospice providers licensed under chapter 144A; boarding care homes or supervised living 
73.1 	facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities 
73.2 	owned, controlled, managed, or under common control with hospitals licensed under chapter 
73.3 	144; and other health care facilities licensed by the commissioner of health or the 
73.4 	commissioner of human services may adopt reasonable restrictions on the use of medical
73.5 	cannabis flower or medical cannabinoid, cannabis products, lower-potency hemp edibles, 
73.6 	hemp-derived consumer products, or hemp-derived topical products by a patient enrolled 
73.7 	in the registry program who resides at or is actively receiving treatment or care at the facility. 
73.8 	The restrictions may include a provision that the facility must not store or maintain a patient's 
73.9 	supply of medical cannabis flower or medical cannabinoid cannabis products on behalf of 
73.10 	the patient; that a patient store the patient's supply of medical cannabis flower or medicinal 
73.11 	cannabinoid, cannabis products, lower-potency hemp edibles, hemp-derived consumer 
73.12 	products, or hemp-derived topical products in a locked container accessible only to the 
73.13 	patient, the patient's designated caregiver, or the patient's parent, legal guardian, or spouse; 
73.14 	that the facility is not responsible for providing medical cannabis or hemp for patients; and 
73.15 	that medical cannabis flower or medical cannabinoid, cannabis products, lower-potency 
73.16 	hemp edibles, hemp-derived consumer products, or hemp-derived topical products are used 
73.17 	only in a location specified by the facility or provider. Nothing in this subdivision requires 
73.18 	facilities and providers listed in this subdivision to adopt such restrictions.
73.19 	(b) No facility or provider listed in this subdivision may unreasonably limit a patient's 
73.20 	access to or use of medical cannabis flower or medical cannabinoid, cannabis products, 
73.21 	lower-potency hemp edibles, hemp-derived consumer products, or hemp-derived topical 
73.22 	products to the extent that such use is authorized under sections 342.51 to 342.59, or, in the 
73.23 	case of a visiting patient, authorized to use cannabis under the laws of their state of residence. 
73.24 	No facility or provider listed in this subdivision may prohibit a patient access to or use of 
73.25 	medical cannabis flower or medical cannabinoid cannabis products due solely to the fact 
73.26 	that cannabis is a controlled substance pursuant to the federal Uniform Controlled Substances 
73.27 	Act. If a federal regulatory agency, the United States Department of Justice, or the federal 
73.28 	Centers for Medicare and Medicaid Services takes one of the following actions, a facility 
73.29 	or provider may suspend compliance with this paragraph until the regulatory agency, the 
73.30 	United States Department of Justice, or the federal Centers for Medicare and Medicaid 
73.31 	Services notifies the facility or provider that it may resume permitting the use of medical
73.32 	cannabis flower or medical cannabinoid, cannabis products, lower-potency hemp edibles, 
73.33 	hemp-derived consumer products, or hemp-derived topical products within the facility or 
73.34 	in the provider's service setting:
74.1 	(1) a federal regulatory agency or the United States Department of Justice initiates 
74.2 	enforcement action against a facility or provider related to the facility's compliance with 
74.3 	the medical cannabis program; or
74.4 	(2) a federal regulatory agency, the United States Department of Justice, or the federal 
74.5 	Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification 
74.6 	to the facility or provider that expressly prohibits the use of medical cannabis in health care 
74.7 	facilities or otherwise prohibits compliance with the medical cannabis program.
74.8 	(c) An employee or agent of a facility or provider listed in this subdivision or a person 
74.9 	licensed under chapter 144E is not violating this chapter or chapter 152 for the possession 
74.10 	of medical cannabis flower or medical cannabinoid cannabis products while carrying out 
74.11 	employment duties, including providing or supervising care to a patient enrolled in the 
74.12 	registry program, or distribution of medical cannabis flower or medical cannabinoid cannabis
74.13 	products to a patient enrolled in the registry program who resides at or is actively receiving 
74.14 	treatment or care at the facility or from the provider with which the employee or agent is 
74.15 	affiliated.
74.16 	(d) Nothing in this subdivision is intended to require a facility covered by this subdivision 
74.17 	to permit violations of sections 144.411 to 144.417.
74.18 	(e) This subdivision does not apply to sober homes under section 254B.181, except that 
74.19 	a resident of a sober home who is a patient enrolled in the registry program must have access 
74.20 	to medical cannabis flower and medical cannabinoid products subject to the restrictions and 
74.21 	requirements in paragraphs (a) and (b).

74.22 	Sec. 94. Minnesota Statutes 2024, section 342.57, is amended to read:
74.23 	342.57 PROTECTIONS FOR REGISTRY PROGRAM PARTICIPANTS.
74.24 		Subdivision 1.Presumption. (a) There is a presumption that a patient or other person
74.25 	an individual enrolled in the registry program or a Tribal medical cannabis program patient 
74.26 	is engaged in the authorized use or possession of medical cannabis flower and medical 
74.27 	cannabinoid products.
74.28 	(b) This presumption may be rebutted by evidence that:
74.29 	(1) the use or possession of medical cannabis flower or medical cannabinoid products 
74.30 	by a patient or other person enrolled in the registry program was not for the purpose of 
74.31 	assisting with, treating, or alleviating the patient's qualifying medical condition or symptoms 
74.32 	associated with the patient's qualifying medical condition.; or
75.1 	(2) a Tribal medical cannabis program patient's use of medical cannabis was not for a 
75.2 	purpose authorized by the Tribal medical cannabis program.
75.3 		Subd. 2.Criminal and civil protections. (a) Subject to section 342.56, the following 
75.4 	are not violations of this chapter or chapter 152:
75.5 	(1) use or possession of medical cannabis flower, medical cannabinoid products, or 
75.6 	medical cannabis paraphernalia by a patient enrolled in the registry program or by, a visiting 
75.7 	patient, or a Tribal medical cannabis program patient to whom medical cannabis flower or 
75.8 	medical cannabinoid products are distributed under section 342.51, subdivision 5;
75.9 	(2) possession of medical cannabis flower, medical cannabinoid products, or medical 
75.10 	cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or 
75.11 	spouse of a patient enrolled in the registry program; or
75.12 	(3) possession of medical cannabis flower, medical cannabinoid products, or medical 
75.13 	cannabis paraphernalia by any person while carrying out duties required under sections 
75.14 	342.51 to 342.60.
75.15 	(b) The Office of Cannabis Management, members of the Cannabis Advisory Council, 
75.16 	Office of Cannabis Management employees, agents or contractors of the Office of Cannabis 
75.17 	Management, members of a Tribal medical cannabis board, a Tribal medical cannabis board's 
75.18 	staff, a Tribal medical cannabis board's agents or contractors, and health care practitioners 
75.19 	participating in the registry program are not subject to any civil penalties or disciplinary 
75.20 	action by the Board of Medical Practice, the Board of Nursing, or any business, occupational, 
75.21 	or professional licensing board or entity solely for participating in the registry program or 
75.22 	a Tribal medical cannabis program either in a professional capacity or as a patient. A 
75.23 	pharmacist licensed under chapter 151 is not subject to any civil penalties or disciplinary 
75.24 	action by the Board of Pharmacy when acting in accordance with sections 342.51 to 342.60
75.25 	either in a professional capacity or as a patient. Nothing in this section prohibits a professional 
75.26 	licensing board from taking action in response to a violation of law.
75.27 	(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the 
75.28 	governor, or an employee of a state agency must not be held civilly or criminally liable for 
75.29 	any injury, loss of property, personal injury, or death caused by any act or omission while 
75.30 	acting within the scope of office or employment under sections 342.51 to 342.60.
75.31 	(d) Federal, state, and local law enforcement authorities are prohibited from accessing 
75.32 	the registry except when acting pursuant to a valid search warrant. Notwithstanding section 
75.33 	13.09, a violation of this paragraph is a gross misdemeanor.
76.1 	(e) Notwithstanding any law to the contrary, the office and employees of the office must 
76.2 	not release data or information about an individual contained in any report or document or 
76.3 	in the registry and must not release data or information obtained about a patient enrolled in 
76.4 	the registry program, except as provided in sections 342.51 to 342.60. Notwithstanding 
76.5 	section 13.09, a violation of this paragraph is a gross misdemeanor.
76.6 	(f) No information contained in a report or document, contained in the registry, or 
76.7 	obtained from a patient under sections 342.51 to 342.60or from a Tribal medical cannabis 
76.8 	program patient may be admitted as evidence in a criminal proceeding, unless:
76.9 	(1) the information is independently obtained; or
76.10 	(2) admission of the information is sought in a criminal proceeding involving a criminal 
76.11 	violation of sections 342.51 to 342.60.
76.12 	(g) Possession of a registry verification or an application for enrollment in the registry 
76.13 	program and possession of a registry verification or its equivalent issued by a Tribal medical 
76.14 	cannabis program or application for enrollment in a Tribal medical cannabis program by a 
76.15 	person entitled to possess the verification or application:
76.16 	(1) does not constitute probable cause or reasonable suspicion;
76.17 	(2) must not be used to support a search of the person or property of the person with a 
76.18 	registry verification or application to enroll in the registry program; and
76.19 	(3) must not subject the person or the property of the person to inspection by any 
76.20 	government agency.
76.21 	(h) A patient enrolled in the registry program or a Tribal medical cannabis program must 
76.22 	not be subject to any penalty or disciplinary action by an occupational or a professional 
76.23 	licensing board solely because:
76.24 	(1) the patient is enrolled in the registry program or in a Tribal medical cannabis program; 
76.25 	or
76.26 	(2) the patient has a positive test for cannabis components or metabolites.
76.27 		Subd. 3.School enrollment; rental property. (a) No school may refuse to enroll or 
76.28 	otherwise penalize a patient or person enrolled in the registry program or a Tribal medical 
76.29 	cannabis program as a pupil solely because the patient or person is enrolled in the registry 
76.30 	program or a Tribal medical cannabis program, unless failing to do so would violate federal 
76.31 	law or regulations or cause the school to lose a monetary or licensing-related benefit under 
76.32 	federal law or regulations.
77.1 	(b) No landlord may refuse to lease to a patient or person enrolled in the registry program 
77.2 	or a Tribal medical cannabis program or otherwise penalize a patient or person enrolled in 
77.3 	the registry program or a Tribal medical cannabis program solely because the patient or 
77.4 	person is enrolled in the registry program or a Tribal medical cannabis program, unless 
77.5 	failing to do so would violate federal law or regulations or cause the landlord to lose a 
77.6 	monetary or licensing-related benefit under federal law or regulations.
77.7 	(c) A school must not refuse to enroll a patient as a pupil solely because cannabis is a 
77.8 	controlled substance according to the Uniform Controlled Substances Act, United States 
77.9 	Code, title 21, section 812.
77.10 	(d) A school must not penalize a pupil who is a patient solely because cannabis is a 
77.11 	controlled substance according to the Uniform Controlled Substances Act, United States 
77.12 	Code, title 21, section 812.
77.13 	(e) A landlord must not refuse to lease a property to a patient solely because cannabis 
77.14 	is a controlled substance according to the Uniform Controlled Substances Act, United States 
77.15 	Code, title 21, section 812.
77.16 	(f) A landlord must not otherwise penalize a patient solely because cannabis is a controlled 
77.17 	substance according to the Uniform Controlled Substances Act, United States Code, title 
77.18 	21, section 812.
77.19 		Subd. 4.Medical care. For purposes of medical care, including organ transplants, a 
77.20 	patient's use of medical cannabis flower or medical cannabinoid products according to 
77.21 	sections 342.51 to 342.60, or a Tribal medical cannabis program patient's use of medical 
77.22 	cannabis as authorized by a Tribal medical cannabis program, is considered the equivalent 
77.23 	of the authorized use of a medication used at the discretion of a health care practitioner and 
77.24 	does not disqualify a patient from needed medical care.
77.25 		Subd. 5.Employment. (a) Unless a failure to do so would violate federal or state law 
77.26 	or regulations or cause an employer to lose a monetary or licensing-related benefit under 
77.27 	federal law or regulations, an employer may not discriminate against a person in hiring, 
77.28 	termination, or any term or condition of employment, or otherwise penalize a person, if the 
77.29 	discrimination is based on:
77.30 	(1) the person's status as a patient or person an individual enrolled in the registry program; 
77.31 	or
77.32 	(2) the person's status as a Tribal medical cannabis program patient; or
78.1 	(2) (3) a patient's positive drug test for cannabis components or metabolites, unless the 
78.2 	patient used, possessed, sold, transported, or was impaired by medical cannabis flower or 
78.3 	a medical cannabinoid product on work premises, during working hours, or while operating 
78.4 	an employer's machinery, vehicle, or equipment.
78.5 	(b) An employee who is a patient in the registry program or a Tribal medical cannabis 
78.6 	program and whose employer requires the employee to undergo drug testing according to 
78.7 	section 181.953 may present the employee's registry verification or verification of enrollment 
78.8 	in a Tribal medical cannabis program as part of the employee's explanation under section 
78.9 	181.953, subdivision 6.
78.10 		Subd. 5a.Notice. An employer, a school, or a landlord must provide written notice to 
78.11 	a patient at least 14 days before the employer, school, or landlord takes an action against 
78.12 	the patient that is prohibited under subdivision 3 or 5. The written notice must cite the 
78.13 	specific federal law or regulation that the employer, school, or landlord believes would be 
78.14 	violated if the employer, school, or landlord fails to take action. The notice must specify 
78.15 	what monetary or licensing-related benefit under federal law or regulations that the employer, 
78.16 	school, or landlord would lose if the employer, school, or landlord fails to take action.
78.17 		Subd. 6.Custody; visitation; parenting time. A person An individual must not be 
78.18 	denied custody of a minor child or visitation rights or parenting time with a minor child 
78.19 	based solely on the person's individual's status as a patient or person an individual enrolled 
78.20 	in the registry program or on the individual's status as a Tribal medical cannabis program 
78.21 	patient. There must be no presumption of neglect or child endangerment for conduct allowed 
78.22 	under sections 342.51 to 342.60 or under a Tribal medical cannabis program, unless the 
78.23 	person's individual's behavior creates an unreasonable danger to the safety of the minor as 
78.24 	established by clear and convincing evidence.
78.25 		Subd. 6a.Retaliation prohibited. A school, a landlord, a health care facility, or an 
78.26 	employer must not retaliate against a patient for asserting the patient's rights or seeking 
78.27 	remedies under this section or section 152.32.
78.28 		Subd. 7.Action for damages; injunctive relief. In addition to any other remedy provided 
78.29 	by law, a patient or person an individual enrolled in the registry program or a Tribal medical 
78.30 	cannabis program may bring an action for damages against any person who violates 
78.31 	subdivision 3, 4, or 5. A person who violates subdivision 3, 4, or 5 is liable to a patient or 
78.32 	person an individual enrolled in the registry program or a Tribal medical cannabis program 
78.33 	injured by the violation for the greater of the person's actual damages or a civil penalty of 
79.1 	$100 $1,000 and reasonable attorney fees. A patient may bring an action for injunctive relief 
79.2 	to prevent or end a violation of subdivisions 3 to 6a.
79.3 		Subd. 8.Sanctions restricted for those on parole, supervised release, or conditional 
79.4 	release. (a) This subdivision applies to an individual placed on parole, supervised release, 
79.5 	or conditional release.
79.6 	(b) The commissioner of corrections may not:
79.7 	(1) prohibit an individual from participating in the registry program or a Tribal medical 
79.8 	cannabis program as a condition of release; or
79.9 	(2) revoke an individual's parole, supervised release, or conditional release or otherwise 
79.10 	sanction an individual solely:
79.11 	(i) for participating in the registry program or a Tribal medical cannabis program; or
79.12 	(ii) for a positive drug test for cannabis components or metabolites.

79.13 	Sec. 95. Minnesota Statutes 2024, section 342.59, subdivision 2, is amended to read:
79.14 		Subd. 2.Allowable use; prohibited use. Data specified in subdivision 1 may be used 
79.15 	to comply with chapter 13, to comply with a request from the legislative auditor or the state 
79.16 	auditor in the performance of official duties, and for purposes specified in sections 342.47
79.17 	342.51to 342.60. Data specified in subdivision 1 and maintained by the Office of Cannabis 
79.18 	Management or Division of Medical Cannabis must not be used for any purpose not specified 
79.19 	in sections 342.47342.51to 342.60 and must not be combined or linked in any manner 
79.20 	with any other list, dataset, or database. Data specified in subdivision 1 must not be shared 
79.21 	with any federal agency, federal department, or federal entity unless specifically ordered 
79.22 	to do so by a state or federal court.

79.23 	Sec. 96. Minnesota Statutes 2024, section 342.61, subdivision 4, is amended to read:
79.24 		Subd. 4.Testing of samples; disclosures. (a) On a schedule determined by the office, 
79.25 	every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
79.26 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
79.27 	hemp edible manufacturer, or medical cannabis combination business shall make each batch 
79.28 	of cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency 
79.29 	hemp edibles, or hemp-derived consumer products grown, manufactured, or imported by 
79.30 	the cannabis business or hemp business available to a cannabis testing facility.
80.1 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
80.2 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
80.3 	hemp edible manufacturer, or medical cannabis combination business must disclose all 
80.4 	known information regarding pesticides, fertilizers, solvents, or other foreign materials, 
80.5 	including but not limited to catalysts used in creating artificially derived cannabinoids, 
80.6 	applied or added to the batch of cannabis flower, cannabis products, artificially derived 
80.7 	cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products subject to 
80.8 	testing. Disclosure must be made to the cannabis testing facility and must include information 
80.9 	about all applications by any person, whether intentional or accidental.
80.10 	(c) The A cannabis testing facility business shall select one or more representative 
80.11 	samples from each batch, test the samples for the presence of contaminants, and test the 
80.12 	samples for potency and homogeneity and to allow the cannabis flower, cannabis product, 
80.13 	artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer 
80.14 	product to be accurately labeled with its cannabinoid profile. Testing for contaminants must 
80.15 	include testing for residual solvents, foreign material, microbiological contaminants, heavy 
80.16 	metals, pesticide residue, mycotoxins, and any items identified pursuant to paragraph (b), 
80.17 	and may include testing for other contaminants. A cannabis testing facility must destroy or 
80.18 	return to the cannabis business or hemp business any part of the sample that remains after 
80.19 	testing.

80.20 	Sec. 97. Minnesota Statutes 2024, section 342.62, subdivision 2, is amended to read:
80.21 		Subd. 2.Packaging requirements. (a) Except as provided in paragraph (b), all cannabis 
80.22 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
80.23 	sold to customers or patients must be:
80.24 	(1) prepackaged in packaging or a container that is child-resistant, tamper-evident, and 
80.25 	opaque; or
80.26 	(2) placed in packaging or a container that is plain, child-resistant, tamper-evident, and 
80.27 	opaque at the final point of sale to a customer.
80.28 	(b) The requirement that packaging be child-resistant does not apply to a lower-potency 
80.29 	hemp edible that is intended to be consumed as a beverage.
80.30 	(c) If a cannabis product, lower-potency hemp edible, or a hemp-derived consumer 
80.31 	product is packaged in a manner that includes more than a single serving, each serving must 
80.32 	be indicated by scoring, wrapping, or other indicators designating the individual serving 
81.1 	size. If the item is a lower-potency hemp edible, serving indicators must meet the 
81.2 	requirements of section 342.46, subdivision 6, paragraph (b).
81.3 	(d) Notwithstanding paragraph (c), any edible cannabinoid products that are intended 
81.4 	to be combined with food or beverage products before consumption must indicate a single 
81.5 	serving using one of the following methods:
81.6 	(1) the product is packaged in individual servings;
81.7 	(2) the product indicates a single serving by scoring or use of another indicator that 
81.8 	appears on the product; or
81.9 	(3) the product is sold with a calibrated dropper, measuring spoon, or similar device for 
81.10 	measuring a single serving.
81.11 	(e) A package containing multiple servings of a lower-potency hemp edible that is not 
81.12 	intended to be consumed as a beverage must not contain:
81.13 	(1) more than 50 milligrams of delta-9 tetrahydrocannabinol;
81.14 	(2) more than 1,000 milligrams of cannabidiol, cannabigerol, cannabinol, or 
81.15 	cannabichromene:
81.16 	(3) more than the established limit of any other cannabinoid authorized by the office; 
81.17 	or
81.18 	(4) any combination of those cannabinoids that exceeds the identified amounts for the 
81.19 	applicable product category.
81.20 	(f) A single container containing a lower-potency hemp edible product that is intended 
81.21 	to be consumed as a beverage must not contain:
81.22 	(1) more than ten milligrams of delta-9 tetrahydrocannabinol;
81.23 	(2) more than 200 milligrams of cannabidiol, cannabigerol, cannabinol, or 
81.24 	cannabichromene;
81.25 	(3) more than the established limit of any other cannabinoid authorized by the office; 
81.26 	or
81.27 	(4) any combination of those cannabinoids that exceeds the identified amounts for the 
81.28 	applicable product category.
81.29 	(d) (g) Edible cannabis products and lower-potency hemp edibles containing more than 
81.30 	a single serving must be prepackaged or placed at the final point of sale in packaging or a 
81.31 	container that is resealable.

82.1 	Sec. 98. Minnesota Statutes 2024, section 342.63, subdivision 2, is amended to read:
82.2 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
82.3 	products that consist of hemp plant parts sold to customers or patients must have affixed 
82.4 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
82.5 	label that contains at least the following information:
82.6 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
82.7 	cannabis cultivator, medical cannabis combination business, or industrial hemp grower 
82.8 	where the cannabis flower or hemp plant part was cultivated;
82.9 	(2) the net weight or volume of cannabis flower or hemp plant parts in the package or 
82.10 	container;
82.11 	(3) the batch number;
82.12 	(4) the cannabinoid profile;
82.13 	(5) a universal symbol established by the office indicating that the package or container 
82.14 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
82.15 	hemp-derived consumer product;
82.16 	(6) verification that the cannabis flower or hemp plant part was tested according to 
82.17 	section 342.61 and that the cannabis flower or hemp plant part complies with the applicable 
82.18 	standards;
82.19 	(7) information on the usage of the cannabis flower or hemp-derived consumer product;
82.20 	(8) the following statement: "Keep this product out of reach of children."; and
82.21 	(9) any other statements or information required by the office.

82.22 	Sec. 99. Minnesota Statutes 2024, section 342.63, subdivision 3, is amended to read:
82.23 		Subd. 3.Content of label; cannabinoid products. (a) All cannabis products, 
82.24 	lower-potency hemp edibles, hemp concentrate, hemp-derived consumer products other 
82.25 	than products subject to the requirements under subdivision 2, medical cannabinoid products, 
82.26 	and hemp-derived topical products sold to customers or patients must have affixed to the 
82.27 	packaging or container of the cannabis product a label that contains at least the following 
82.28 	information:
82.29 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
82.30 	cannabis cultivator, medical cannabis combination business, or industrial hemp grower that 
82.31 	cultivated the cannabis flower or hemp plant parts used in the cannabis product, 
83.1 	lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid 
83.2 	product;
83.3 	(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
83.4 	cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis 
83.5 	combination business, or industrial hemp grower that manufactured the cannabis concentrate, 
83.6 	hemp concentrate, or artificially derived cannabinoid and, if different, the name and license 
83.7 	number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, 
83.8 	lower-potency hemp edible manufacturer, or medical cannabis combination business that 
83.9 	manufactured the product;
83.10 	(3) the net weight or volume of the cannabis product, lower-potency hemp edible, or 
83.11 	hemp-derived consumer product in the package or container;
83.12 	(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer 
83.13 	product;
83.14 	(5) the batch number;
83.15 	(6) the serving size;
83.16 	(7) the cannabinoid profile per serving and in total;
83.17 	(8) a list of ingredients;
83.18 	(9) a universal symbol established by the office indicating that the package or container 
83.19 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
83.20 	hemp-derived consumer product;
83.21 	(10) a warning symbol developed by the office in consultation with the commissioner 
83.22 	of health and the Minnesota Poison Control System that:
83.23 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
83.24 	(ii) is in a highly visible color;
83.25 	(iii) includes a visual element that is commonly understood to mean a person should 
83.26 	stop;
83.27 	(iv) indicates that the product is not for children; and
83.28 	(v) includes the phone number of the Minnesota Poison Control System;
83.29 	(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
83.30 	consumer product, or medical cannabinoid product was tested according to section 342.61 
84.1 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
84.2 	or medical cannabinoid product complies with the applicable standards;
84.3 	(12) information on the usage of the product;
84.4 	(13) the following statement: "Keep this product out of reach of children."; and
84.5 	(14) any other statements or information required by the office.
84.6 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
84.7 	hemp edibles that are imported into the state if those requirements provide consumers with 
84.8 	information that is substantially similar to the information described in paragraph (a).

84.9 	Sec. 100. Minnesota Statutes 2024, section 342.63, subdivision 5, is amended to read:
84.10 		Subd. 5.Content of label; hemp-derived topical products. (a) All hemp-derived topical 
84.11 	products sold to customers must have affixed to the packaging or container of the product 
84.12 	a label that contains at least the following information:
84.13 	(1) the manufacturer name, location, phone number, and website;
84.14 	(2) the name and address of the independent, accredited laboratory used by the 
84.15 	manufacturer to test the product;
84.16 	(3) the net weight or volume of the product in the package or container;
84.17 	(4) the type of topical product;
84.18 	(5) the amount or percentage of cannabidiol, cannabigerol, or any other cannabinoid, 
84.19 	derivative, or extract of hemp, per serving and in total;
84.20 	(6) a list of ingredients;
84.21 	(7) a statement that the product does not claim to diagnose, treat, cure, or prevent any 
84.22 	disease and that the product has not been evaluated or approved by the United States Food 
84.23 	and Drug Administration, unless the product has been so approved; and
84.24 	(8) any other statements or information required by the office.
84.25 	(b) The information required in paragraph (a), clauses (1), (2), and (5), may be provided 
84.26 	through the use of a scannable barcode or matrix barcode that links to a page on a website 
84.27 	maintained by the manufacturer or distributor if that page contains all of the information 
84.28 	required by this subdivision.

85.1 	Sec. 101. Minnesota Statutes 2024, section 342.63, subdivision 6, is amended to read:
85.2 		Subd. 6.Additional information. (a) A cannabis microbusiness, cannabis mezzobusiness, 
85.3 	cannabis retailer, or medical cannabis combination business must provide customers and 
85.4 	patients with the following information:
85.5 	(1) factual information about impairment effects and the expected timing of impairment 
85.6 	effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, 
85.7 	lower-potency hemp edibles, and hemp-derived consumer products;
85.8 	(2) a statement that customers and patients must not operate a motor vehicle or heavy 
85.9 	machinery while under the influence of cannabis flower, cannabis products, lower-potency 
85.10 	hemp edibles, and hemp-derived consumer products;
85.11 	(3) resources customers and patients may consult to answer questions about cannabis 
85.12 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
85.13 	products, and any side effects and adverse effects;
85.14 	(4) contact information for the poison control center and a safety hotline or website for 
85.15 	customers to report and obtain advice about side effects and adverse effects of cannabis 
85.16 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
85.17 	products;
85.18 	(5) substance use disorder treatment options; and
85.19 	(6) any other information specified by the office.
85.20 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical 
85.21 	cannabis combination business may include the information described in paragraph (a) by:
85.22 	(1) including the information on the label affixed to the packaging or container of cannabis 
85.23 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products 
85.24 	by:;
85.25 	(1) (2) posting the information in the premises of the cannabis microbusiness, cannabis 
85.26 	mezzobusiness, cannabis retailer, or medical cannabis combination business; or
85.27 	(2) (3) providing the information on a separate document or pamphlet provided to 
85.28 	customers or patients when the customer purchases cannabis flower, a cannabis product, a 
85.29 	lower-potency hemp edible, or a hemp-derived consumer product.

86.1 	Sec. 102. Minnesota Statutes 2024, section 342.66, subdivision 6, is amended to read:
86.2 		Subd. 6.Prohibitions. (a) A product sold to consumers under this section must not be 
86.3 	manufactured, marketed, distributed, or intended:
86.4 	(1) for external or internal use in the diagnosis, cure, mitigation, treatment, or prevention 
86.5 	of disease in humans or other animals;
86.6 	(2) to affect the structure or any function of the bodies of humans or other animals;
86.7 	(3) to be consumed by combustion or vaporization of the product and inhalation of 
86.8 	smoke, aerosol, or vapor from the product;
86.9 	(4) to be consumed through chewing; or
86.10 	(5) to be consumed through injection or application to nonintact skin or a mucous 
86.11 	membrane or nonintact skin, except for products applied sublingually.
86.12 	(b) A product manufactured, marketed, distributed, or sold to consumers under this 
86.13 	section must not:
86.14 	(1) consist, in whole or in part, of any filthy, putrid, or decomposed substance;
86.15 	(2) have been produced, prepared, packed, or held under unsanitary conditions where 
86.16 	the product may have been rendered injurious to health, or where the product may have 
86.17 	been contaminated with filth;
86.18 	(3) be packaged in a container that is composed, in whole or in part, of any poisonous 
86.19 	or deleterious substance that may render the contents injurious to health;
86.20 	(4) contain any additives or excipients that have been found by the United States Food 
86.21 	and Drug Administration to be unsafe for human or animal consumption;
86.22 	(5) contain a cannabinoid or an amount or percentage of cannabinoids that is different 
86.23 	than the information stated on the label;
86.24 	(6) contain a cannabinoid, other than cannabidiol, cannabigerol, or a cannabinoid 
86.25 	approved by the office, in an amount that exceeds the standard established in subdivision 
86.26 	2 3, paragraph (c); or
86.27 	(7) contain any contaminants for which testing is required by the office in amounts that 
86.28 	exceed the acceptable minimum standards established by the office.
86.29 	(c) No product containing any cannabinoid may be sold to any individual who is under 
86.30 	21 years of age.

87.1 	Sec. 103. Minnesota Statutes 2024, section 609A.06, subdivision 3, is amended to read:
87.2 		Subd. 3.Eligibility; cannabis offense. (a) A person is eligible for an expungement or 
87.3 	resentencing to a lesser offense if:
87.4 	(1) the person was convicted of, or adjudication was stayed for, a violation of any of the 
87.5 	following a first-, second-, third-, fourth-, or fifth-degree controlled substance crime involving 
87.6 	the sale or possession of marijuana or tetrahydrocannabinols:
87.7 	(i) section 152.021, subdivision 1, clause (6);
87.8 	(ii) section 152.021, subdivision 2, clause (6);
87.9 	(iii) section 152.022, subdivision 1, clause (5), or clause (7), item (iii);
87.10 	(iv) section 152.022, subdivision 2, clause (6);
87.11 	(v) section 152.023, subdivision 1, clause (5);
87.12 	(vi) section 152.023, subdivision 2, clause (5);
87.13 	(vii) section 152.024, subdivision (4); or
87.14 	(viii) section 152.025, subdivision 2, clause (1) under Minnesota Statutes 2023 
87.15 	Supplement, section 152.021, 152.022, 152.023, 152.024, or 152.025, or a previous version 
87.16 	of those or any other statutes criminalizing the possession, sale, transportation, or cultivation 
87.17 	of marijuana or tetrahydrocannabinols;
87.18 	(2) the offense did not involve a dangerous weapon, the intentional infliction of bodily 
87.19 	harm on another, an attempt to inflict bodily harm on another, or an act committed with the 
87.20 	intent to cause fear in another of immediate bodily harm or death;
87.21 	(3) the act on which the charge was based would either be a lesser offense or no longer 
87.22 	be a crime after August 1, 2023; and
87.23 	(4) the person did not appeal the conviction, any appeal was denied, or the deadline to 
87.24 	file an appeal has expired.
87.25 	(b) A person who is eligible for an expungement under paragraph (a) is also eligible for 
87.26 	an expungement of any other cannabis-related offense that was charged along with the 
87.27 	underlying crime described in paragraph (a) and was dismissed.
87.28 	(c) For purposes of this subdivision, a section, the following terms have the meanings 
87.29 	given:
88.1 	(1) "cannabis-related offense" means an offense described in paragraph (a), clause (1), 
88.2 	and also includes an offense described in Minnesota Statutes 2022, section 152.027, 
88.3 	subdivisions 3 and 4; and
88.4 	(2) "lesser offense" means a nonfelony offense if the person was charged with a felony.

88.5 	Sec. 104. Minnesota Statutes 2024, section 609A.06, subdivision 7, is amended to read:
88.6 		Subd. 7.Review and determination. (a) The Cannabis Expungement Board shall review 
88.7 	all available records to determine whether the conviction or stay of adjudication is eligible 
88.8 	for an expungement or resentencing to a lesser offense and, if so, whether any dismissed 
88.9 	cannabis-related offense is also eligible for expungement. An expungement under this 
88.10 	section is presumed to be in the public interest unless there is clear and convincing evidence 
88.11 	that an expungement or resentencing to a lesser offense would create a risk to public safety.
88.12 	(b) If the Cannabis Expungement Board determines that an expungement is in the public 
88.13 	interest, the board shall determine whether a person's conviction should be vacated and 
88.14 	charges should be dismissed.
88.15 	(c) If the Cannabis Expungement Board determines that an expungement is in the public 
88.16 	interest, the board shall determine whether the limitations under section 609A.03, subdivision 
88.17 	5a, apply.
88.18 	(d) If the Cannabis Expungement Board determines that an expungement is in the public 
88.19 	interest, the board shall determine whether the limitations under section 609A.03, subdivision 
88.20 	7a, paragraph (b), clause (5), apply.
88.21 	(e) If the Cannabis Expungement Board determines that an expungement is not in the 
88.22 	public interest, the board shall determine whether the person is eligible for resentencing to 
88.23 	a lesser offense.
88.24 	(f) In making a determination under this subdivision, the Cannabis Expungement Board 
88.25 	shall consider:
88.26 	(1) the nature and severity of the underlying crime, including but not limited to the total 
88.27 	amount of marijuana or tetrahydrocannabinols possessed by the person and whether the 
88.28 	offense involved a dangerous weapon, the intentional infliction of bodily harm on another, 
88.29 	an attempt to inflict bodily harm on another, or an act committed with the intent to cause 
88.30 	fear in another of immediate bodily harm or death;
88.31 	(2) whether an expungement or resentencing the person a lesser offense would increase 
88.32 	the risk, if any, the person poses to other individuals or society;
89.1 	(3) if the person is under sentence, whether an expungement or resentencing to a lesser 
89.2 	offense would result in the release of the person and whether release earlier than the date 
89.3 	that the person would be released under the sentence currently being served would present 
89.4 	a danger to the public or would be compatible with the welfare of society;
89.5 	(4) aggravating or mitigating factors relating to the underlying crime, including the 
89.6 	person's level of participation and the context and circumstances of the underlying crime;
89.7 	(5) statements from victims and law enforcement, if any;
89.8 	(6) if an expungement or resentencing the person to a lesser offense is considered, 
89.9 	whether there is good cause to restore the person's right to possess firearms and ammunition;
89.10 	(7) if an expungement is considered, whether an expunged record of a conviction or stay 
89.11 	of adjudication may be opened for purposes of a background check required under section 
89.12 	122A.18, subdivision 8; and
89.13 	(8) whether the person was also charged with other offenses in addition to the underlying 
89.14 	crime, the disposition of those other charges, and other factors deemed relevant by the 
89.15 	Cannabis Expungement Board.
89.16 	(g) In making a determination under this subdivision, the Cannabis Expungement Board 
89.17 	shall not consider the impact the expungement would have on the offender based on any 
89.18 	records held by the Department of Health; Department of Children, Youth, and Families; 
89.19 	or Department of Human Services.
89.20 	(h) The affirmative vote of three members is required for action taken at any meeting.

89.21 	Sec. 105. Minnesota Statutes 2024, section 609A.06, subdivision 10, is amended to read:
89.22 		Subd. 10.Notice to judicial branch and offenders. (a) The Cannabis Expungement 
89.23 	Board shall identify any conviction or, stay of adjudication, or dismissed cannabis-related 
89.24 	offense that qualifies for an order of expungement or resentencing to a lesser offense and 
89.25 	notify the judicial branch of:
89.26 	(1) the name and date of birth of a person whose conviction or stay of adjudication is 
89.27 	eligible for an order of expungement or resentencing to a lesser offense;
89.28 	(2) the court file number of the eligible conviction or stay of adjudication;
89.29 	(3) whether the person is eligible for an expungement;
89.30 	(4) if the person is eligible for an expungement, whether the person's conviction should 
89.31 	be vacated and charges should be dismissed;
90.1 	(5) if the person is eligible for an expungement, whether there is good cause to restore 
90.2 	the offender's right to possess firearms and ammunition;
90.3 	(6) if the person is eligible for an expungement, whether the limitations under section 
90.4 	609A.03, subdivision 7a, paragraph (b), clause (5), apply; and
90.5 	(7) if the person is eligible for an expungement, whether the expungement should also 
90.6 	apply to any dismissed cannabis-related offense in addition to the underlying crime; and
90.7 	(8) if the person is eligible for resentencing to a lesser offense, the lesser sentence to be 
90.8 	imposed.
90.9 	(b) The Cannabis Expungement Board shall make a reasonable and good faith effort to 
90.10 	notify any person whose conviction or stay of adjudication qualifies for an order of 
90.11 	expungement that the offense qualifies and notice is being sent to the judicial branch. Notice 
90.12 	sent pursuant to this paragraph shall inform the person that, following the order of 
90.13 	expungement, any records of an arrest, conviction, or incarceration should not appear on 
90.14 	any background check or study.

90.15 	Sec. 106. Minnesota Statutes 2024, section 609A.06, subdivision 12, is amended to read:
90.16 		Subd. 12.Order of expungement. (a) Upon receiving notice that an offense qualifies 
90.17 	for expungement, the court shall issue an order sealing all records relating to an arrest, 
90.18 	indictment or information, trial, verdict, or dismissal and discharge for an offense described 
90.19 	in subdivision 3, and any dismissed cannabis-related offense identified by the Cannabis 
90.20 	Expungement Board as eligible for expungement. In addition, the court shall order the 
90.21 	sealing of all records, including those pertaining to probation, incarceration, or supervision, 
90.22 	held by the Department of Corrections or local correctional officials. The courts shall not 
90.23 	order the Department of Health; the Department of Children, Youth, and Families; or the 
90.24 	Department of Human Services to seal records under this section. If the Cannabis 
90.25 	Expungement Board determined that the person's conviction should be vacated and charges 
90.26 	should be dismissed, the order shall vacate and dismiss the charges.
90.27 	(b) If the Cannabis Expungement Board determined that there is good cause to restore 
90.28 	the person's right to possess firearms and ammunition, the court shall issue an order pursuant 
90.29 	to section 609.165, subdivision 1d.
90.30 	(c) If the Cannabis Expungement Board determined that an expunged record of a 
90.31 	conviction or stay of adjudication may not be opened for purposes of a background check 
90.32 	required under section 122A.18, subdivision 8, the court shall direct the order specifically 
90.33 	to the Professional Educator Licensing and Standards Board.
91.1 	(d) The court administrator shall send a copy of an expungement order issued under this 
91.2 	section to each agency and jurisdiction whose records are affected by the terms of the order 
91.3 	and send a letter to the last known address of the person whose offense has been expunged 
91.4 	identifying each agency to which the order was sent.
91.5 	(e) In consultation with the commissioner of human services, the court shall establish a 
91.6 	schedule on which it shall provide the commissioner of human services a list identifying 
91.7 	the name and court file number or, if no court file number is available, the citation number 
91.8 	of each record for a person who received an expungement under this section.
91.9 	(f) Data on the person whose offense has been expunged in a letter sent under this 
91.10 	subdivision are private data on individuals as defined in section 13.02, subdivision 12.

91.11 	Sec. 107. CANNABIS SUPPLY CHAIN STREAMLINING; PROPOSAL.
 91.12 	By January 15, 2026, the Office of Cannabis Management must submit a proposal to 
91.13 	the chairs, co-chairs, and ranking members of the legislative committees and divisions with 
91.14 	jurisdiction over cannabis policy on the streamlining of the cannabis supply chain. The 
91.15 	proposal must address adult-use cannabis and medical cannabis to allow for the cultivation, 
91.16 	manufacturing, storage, and use of equipment in a manner that promotes efficiency, permits 
91.17 	co-location, and authorizes the use of equipment for multiple purposes. The proposal must 
91.18 	preserve access to medical cannabis for rare and childhood diseases.

91.19 	Sec. 108. REPEALER.
 91.20 	Minnesota Statutes 2024, sections 152.22, subdivision 2; 342.151, subdivision 1; and 
91.21 	342.36, subdivision 5, are repealed.

91.22 	Sec. 109. EFFECTIVE DATE.
 91.23 	This act is effective the day following final enactment.

APPENDIX 

Repealed Minnesota Statutes: S2370-3 

152.22 DEFINITIONS.
No active language found for: 152.22.2 

342.151 EMPLOYEES OF LICENSE HOLDERS.
No active language found for: 342.151.1 

342.36 CANNABIS TRANSPORTER OPERATIONS.
No active language found for: 342.36.5